Cell Culture Media Market by Reagent Type (Albumin {Bovine, Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin}, Hormones, Attachment Factors, Amino Acid, Growth factors and Cytokines {Tumor Necrosis Factors, Insulin - Like Growth Factors, Interferons}, Interleukins); by Type (Chemically-Defined Media, Classical Media, Lysogeny Broth, Protein-Free Media, Serum-Free Media, Specialty Media); by Application (Biopharmaceuticals and Therapeutics, Biotech Research, Cancer, Drug Screening and Drug Development, Regenerative Medicine and Tissue Engineering, Stem Cell Technologies); by End User (Biotechnology and Pharmaceutical Companies, Research Laboratories, Academic Institutes, Pathology Labs); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018-2026’

Report ID :AMI-65 | Category : Life Science | Published Date :June, 2018 | Pages : 254 | Format :PDF
Buy Now!

Industry Trends

Cell culture media generally comprises of an appropriate source of energy and compounds which regulate the cell cycle. A typical culture medium is composed of amino acids, vitamins, inorganic salts, glucose, and serum as a source of growth factors, hormones, and attachment factors. In addition to nutrients, the medium also helps in maintaining the pH and osmolality. There are two types of cell culture media available, artificial and natural. Natural media consists solely of naturally occurring biological fluids. They are used for a wide range of animal cell culture. On the other hand, artificial or synthetic media are prepared by adding nutrients, vitamins, salts, O2 and CO2 gas phases, serum proteins, carbohydrates and cofactors.

Cell Culture Media Market, By Region, 2018 – 2026, (USD Million)

Cell Culture Media Market

In terms of revenue, the global cell culture media market was US$ 676.1 Mn in 2017 and is estimated to be US$ 993.25 Mn by 2022.

Cell Culture Media Market, by Application

Cell Culture media has its highest application in biopharmaceuticals and therapeutics. It has been used mainly for treatment of Rheumatoid Arthritis, Crohn’s Disease, Psoriasis, Multiple Sclerosis (MS), Systemic Lupus Erythematosus and many others. It also finds application in the field of dermatology. The most famous derma roller treatment used for removing scars from human skin uses a patient’s cell media extracted from his blood to fill up the scars created by past injuries. As media is rich in protein, it stimulates release of collagen, a compound that inhibits new skin formation. Several such cell culture medias are even used in fasciotomy, hair transplants as well as in various skin grafting surgeries.

Cell Culture Media Market, by Region

The region of North America is expected to gain growth in cell culture media market owing to high technological advancements. The region has witnessed the introduction of new cell culture technologies and protocols with ongoing technological advancements such as multi-faceted bioprocessing systems, the development of 3D cell culture, and automated cell culture instruments. The increasing emphasis on intensive research and development activities to widen the scope of applications in carcinogenesis, mutagenesis, and large-scale manufacturing of biological compounds such as therapeutic proteins and vaccines has also played a critical role in putting North America in the leading position. Johnson & Johnson recently collaborated with Orthocell, an Australian cell culture media company on development of a stem cell-based approach for the regeneration of tendons.

Competitive Landscape

The cell culture media market report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, research institutes, competitors, product type, application and specification, pricing, and gross margin.

Cell culture media market participants include Merck KGaA, BD Biosciences, Cell Essentials, Inc., Quality Biological, Inc., Bio-Techne Corporation (Atlanta Biologicals, Inc.), Affymetrix, Inc., SIAM Bioscience, Novozymes A/S, Thermo Fisher Scientific, Inc., ClonTech Laboratories, Inc. (Takara Bio USA, Inc.), Analytical Biological Services Inc., J R Scientific Inc., MP Biomedicals, SeraCare Life Sciences, Inc., Stemcell Technologies Inc., Lonza, GE Healthcare amongst others. Lonza entered into agreement with TxCell for manufacture of CAR-Treg cellular product, which is in development for the prevention of chronic rejection after organ transplantation.

Cell Culture Media Market Background

Cell Culture Media MarketCell Culture Media Market

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Cell Culture Media Market Snapshot

3.    Executive Summary: Cell Culture Media Market

4.    Qualitative Analysis: Cell Culture Media Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

5.2.1.   Albumin (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin)

5.2.1.1.    Bovine Serum Albumin

5.2.1.2.    Human Serum Albumin

5.2.1.3.    Recombinant Human Serum Albumin

5.2.2.   Hormones

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.2.3.   Attachment Factors

5.2.3.1.    Definition

5.2.3.2.    Market Penetration

5.2.3.3.    Market Revenue Expected to Increase by 2026

5.2.3.4.    Compound Annual Growth Rate (CAGR)

5.2.4.   Amino Acid

5.2.4.1.    Definition

5.2.4.2.    Market Penetration

5.2.4.3.    Market Revenue Expected to Increase by 2026

5.2.4.4.    Compound Annual Growth Rate (CAGR)

5.2.5.   Growth factors and Cytokines (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Tumor Necrosis Factors, Insulin-Like Growth Factors, Interferons, Interleukins)

5.2.5.1.    Tumor Necrosis Factors

5.2.5.2.    Insulin-Like Growth Factors

5.2.5.3.    Interferons

5.2.5.4.    Interleukins

5.3.   Key Segment for Channeling Investments

5.3.1.   By Reagent Type

6.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Market Revenue (US$ Mn) and Forecasts, By Type

6.2.1.   Chemically-Defined Media

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Classical Media

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Lysogeny Broth

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.2.4.   Protein-Free Media

6.2.4.1.    Definition

6.2.4.2.    Market Penetration

6.2.4.3.    Market Revenue Expected to Increase by 2026

6.2.4.4.    Compound Annual Growth Rate (CAGR)

6.2.5.   Serum-Free Media

6.2.5.1.    Definition

6.2.5.2.    Market Penetration

6.2.5.3.    Market Revenue Expected to Increase by 2026

6.2.5.4.    Compound Annual Growth Rate (CAGR)

6.2.6.   Specialty Media

6.2.6.1.    Definition

6.2.6.2.    Market Penetration

6.2.6.3.    Market Revenue Expected to Increase by 2026

6.2.6.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Type

7.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

7.2.1.   Biopharmaceuticals and Therapeutics

7.2.1.1.    Definition

7.2.1.2.    Market Penetration

7.2.1.3.    Market Revenue Expected to Increase by 2026

7.2.1.4.    Compound Annual Growth Rate (CAGR)

7.2.2.   Biotech Research

7.2.2.1.    Definition

7.2.2.2.    Market Penetration

7.2.2.3.    Market Revenue Expected to Increase by 2026

7.2.2.4.    Compound Annual Growth Rate (CAGR)

7.2.3.   Cancer

7.2.3.1.    Definition

7.2.3.2.    Market Penetration

7.2.3.3.    Market Revenue Expected to Increase by 2026

7.2.3.4.    Compound Annual Growth Rate (CAGR)

7.2.4.   Drug Screening and Drug Development

7.2.4.1.    Definition

7.2.4.2.    Market Penetration

7.2.4.3.    Market Revenue Expected to Increase by 2026

7.2.4.4.    Compound Annual Growth Rate (CAGR)

7.2.5.   Regenerative Medicine and Tissue Engineering

7.2.5.1.    Definition

7.2.5.2.    Market Penetration

7.2.5.3.    Market Revenue Expected to Increase by 2026

7.2.5.4.    Compound Annual Growth Rate (CAGR)

7.2.6.   Stem Cell Technologies

7.2.6.1.    Definition

7.2.6.2.    Market Penetration

7.2.6.3.    Market Revenue Expected to Increase by 2026

7.2.6.4.    Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By Application

8.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.2.   Global Market Revenue (US$ Mn) and Forecasts, By End User

8.2.1.   Biotechnology and Pharmaceutical Companies

8.2.1.1.    Definition

8.2.1.2.    Market Penetration

8.2.1.3.    Market Revenue Expected to Increase by 2026

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.2.   Research Laboratories

8.2.2.1.    Definition

8.2.2.2.    Market Penetration

8.2.2.3.    Market Revenue Expected to Increase by 2026

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.3.   Academic Institutes

8.2.3.1.    Definition

8.2.3.2.    Market Penetration

8.2.3.3.    Market Revenue Expected to Increase by 2026

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.4.   Pathology Labs

8.2.4.1.    Definition

8.2.4.2.    Market Penetration

8.2.4.3.    Market Revenue Expected to Increase by 2026

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.3.   Key Segment for Channeling Investments

8.3.1.   By End User

9.    North America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   North America Market Revenue (US$ Mn)

9.2.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.2.1.   Albumin

9.2.1.1.    Bovine Serum Albumin

9.2.1.2.    Human Serum Albumin

9.2.1.3.    Recombinant Human Serum Albumin

9.2.2.   Hormones

9.2.3.   Attachment Factors

9.2.4.   Amino Acid

9.2.5.   Growth factors and Cytokines

9.2.5.1.    Tumor Necrosis Factors

9.2.5.2.    Insulin-Like Growth Factors

9.2.5.3.    Interferons

9.2.5.4.    Interleukins

9.3.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.3.1.   Chemically-Defined Media

9.3.2.   Classical Media

9.3.3.   Lysogeny Broth

9.3.4.   Protein-Free Media

9.3.5.   Serum-Free Media

9.3.6.   Specialty Media

9.4.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.   Biopharmaceuticals and Therapeutics

9.4.2.   Biotech Research

9.4.3.   Cancer

9.4.4.   Drug Screening and Drug Development

9.4.5.   Regenerative Medicine and Tissue Engineering

9.4.6.   Stem Cell Technologies

9.5.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.5.1.   Biotechnology and Pharmaceutical Companies

9.5.2.   Research Laboratories

9.5.3.   Academic Institutes

9.5.4.   Pathology Labs

9.6.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

9.6.1.   U.S.

9.6.1.1.    U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.1.1.1.    Albumin

9.6.1.1.1.1.  Bovine Serum Albumin

9.6.1.1.1.2.  Human Serum Albumin

9.6.1.1.1.3.  Recombinant Human Serum Albumin

9.6.1.1.2.    Hormones

9.6.1.1.3.    Attachment Factors

9.6.1.1.4.    Amino Acid

9.6.1.1.5.    Growth factors and Cytokines

9.6.1.1.5.1.  Tumor Necrosis Factors

9.6.1.1.5.2.  Insulin-Like Growth Factors

9.6.1.1.5.3.  Interferons

9.6.1.1.5.4.  Interleukins

9.6.1.2.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.1.2.1.    Chemically-Defined Media

9.6.1.2.2.    Classical Media

9.6.1.2.3.    Lysogeny Broth

9.6.1.2.4.    Protein-Free Media

9.6.1.2.5.    Serum-Free Media

9.6.1.2.6.    Specialty Media

9.6.1.3.    U.S. Market Revenue (US$ Mn) and Forecasts, By Application

9.6.1.3.1.    Biopharmaceuticals and Therapeutics

9.6.1.3.2.    Biotech Research

9.6.1.3.3.    Cancer

9.6.1.3.4.    Drug Screening and Drug Development

9.6.1.3.5.    Regenerative Medicine and Tissue Engineering

9.6.1.3.6.    Stem Cell Technologies

9.6.1.4.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.1.4.1.    Biotechnology and Pharmaceutical Companies

9.6.1.4.2.    Research Laboratories

9.6.1.4.3.    Academic Institutes

9.6.1.4.4.    Pathology Labs

9.6.2.   Rest of North America

9.6.2.1.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.2.1.1.    Albumin

9.6.2.1.1.1.  Bovine Serum Albumin

9.6.2.1.1.2.  Human Serum Albumin

9.6.2.1.1.3.  Recombinant Human Serum Albumin

9.6.2.1.2.    Hormones

9.6.2.1.3.    Attachment Factors

9.6.2.1.4.    Amino Acid

9.6.2.1.5.    Growth factors and Cytokines

9.6.2.1.5.1.  Tumor Necrosis Factors

9.6.2.1.5.2.  Insulin-Like Growth Factors

9.6.2.1.5.3.  Interferons

9.6.2.1.5.4.  Interleukins

9.6.2.2.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.2.2.1.    Chemically-Defined Media

9.6.2.2.2.    Classical Media

9.6.2.2.3.    Lysogeny Broth

9.6.2.2.4.    Protein-Free Media

9.6.2.2.5.    Serum-Free Media

9.6.2.2.6.    Specialty Media

9.6.2.3.    Rest of North America Market Revenue (US$ Mn) and Forecasts, By Application

9.6.2.3.1.    Biopharmaceuticals and Therapeutics

9.6.2.3.2.    Biotech Research

9.6.2.3.3.    Cancer

9.6.2.3.4.    Drug Screening and Drug Development

9.6.2.3.5.    Regenerative Medicine and Tissue Engineering

9.6.2.3.6.    Stem Cell Technologies

9.6.2.4.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.2.4.1.    Biotechnology and Pharmaceutical Companies

9.6.2.4.2.    Research Laboratories

9.6.2.4.3.    Academic Institutes

9.6.2.4.4.    Pathology Labs

9.7.   Key Segment for Channeling Investments

9.7.1.   By Country

9.7.2.   By Reagent Type

9.7.3.   By Type

9.7.4.   By Application

9.7.5.   By End User

10. Europe Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Europe Market Revenue (US$ Mn)

10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.2.1. Albumin

10.2.1.1.  Bovine Serum Albumin

10.2.1.2.  Human Serum Albumin

10.2.1.3.  Recombinant Human Serum Albumin

10.2.2. Hormones

10.2.3. Attachment Factors

10.2.4. Amino Acid

10.2.5. Growth factors and Cytokines

10.2.5.1.  Tumor Necrosis Factors

10.2.5.2.  Insulin-Like Growth Factors

10.2.5.3.  Interferons

10.2.5.4.  Interleukins

10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.3.1. Chemically-Defined Media

10.3.2. Classical Media

10.3.3. Lysogeny Broth

10.3.4. Protein-Free Media

10.3.5. Serum-Free Media

10.3.6. Specialty Media

10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1. Biopharmaceuticals and Therapeutics

10.4.2. Biotech Research

10.4.3. Cancer

10.4.4. Drug Screening and Drug Development

10.4.5. Regenerative Medicine and Tissue Engineering

10.4.6. Stem Cell Technologies

10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.5.1. Biotechnology and Pharmaceutical Companies

10.5.2. Research Laboratories

10.5.3. Academic Institutes

10.5.4. Pathology Labs

10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

10.6.1. France

10.6.1.1.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.1.1.1.  Albumin

10.6.1.1.1.1.  Bovine Serum Albumin

10.6.1.1.1.2.  Human Serum Albumin

10.6.1.1.1.3.  Recombinant Human Serum Albumin

10.6.1.1.2.  Hormones

10.6.1.1.3.  Attachment Factors

10.6.1.1.4.  Amino Acid

10.6.1.1.5.  Growth factors and Cytokines

10.6.1.1.5.1.  Tumor Necrosis Factors

10.6.1.1.5.2.  Insulin-Like Growth Factors

10.6.1.1.5.3.  Interferons

10.6.1.1.5.4.  Interleukins

10.6.1.2.  France Market Revenue (US$ Mn) and Forecasts, By Type

10.6.1.2.1.  Chemically-Defined Media

10.6.1.2.2.  Classical Media

10.6.1.2.3.  Lysogeny Broth

10.6.1.2.4.  Protein-Free Media

10.6.1.2.5.  Serum-Free Media

10.6.1.2.6.  Specialty Media

10.6.1.3.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.1.3.1.  Biopharmaceuticals and Therapeutics

10.6.1.3.2.  Biotech Research

10.6.1.3.3.  Cancer

10.6.1.3.4.  Drug Screening and Drug Development

10.6.1.3.5.  Regenerative Medicine and Tissue Engineering

10.6.1.3.6.  Stem Cell Technologies

10.6.1.4.  France Market Revenue (US$ Mn) and Forecasts, By End User

10.6.1.4.1.  Biotechnology and Pharmaceutical Companies

10.6.1.4.2.  Research Laboratories

10.6.1.4.3.  Academic Institutes

10.6.1.4.4.  Pathology Labs

10.6.2. The UK

10.6.2.1.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.2.1.1.  Albumin

10.6.2.1.1.1.  Bovine Serum Albumin

10.6.2.1.1.2.  Human Serum Albumin

10.6.2.1.1.3.  Recombinant Human Serum Albumin

10.6.2.1.2.  Hormones

10.6.2.1.3.  Attachment Factors

10.6.2.1.4.  Amino Acid

10.6.2.1.5.  Growth factors and Cytokines

10.6.2.1.5.1.  Tumor Necrosis Factors

10.6.2.1.5.2.  Insulin-Like Growth Factors

10.6.2.1.5.3.  Interferons

10.6.2.1.5.4.  Interleukins

10.6.2.2.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.2.2.1.  Chemically-Defined Media

10.6.2.2.2.  Classical Media

10.6.2.2.3.  Lysogeny Broth

10.6.2.2.4.  Protein-Free Media

10.6.2.2.5.  Serum-Free Media

10.6.2.2.6.  Specialty Media

10.6.2.3.  The UK Market Revenue (US$ Mn) and Forecasts, By Application

10.6.2.3.1.  Biopharmaceuticals and Therapeutics

10.6.2.3.2.  Biotech Research

10.6.2.3.3.  Cancer

10.6.2.3.4.  Drug Screening and Drug Development

10.6.2.3.5.  Regenerative Medicine and Tissue Engineering

10.6.2.3.6.  Stem Cell Technologies

10.6.2.4.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.2.4.1.  Biotechnology and Pharmaceutical Companies

10.6.2.4.2.  Research Laboratories

10.6.2.4.3.  Academic Institutes

10.6.2.4.4.  Pathology Labs

10.6.3. Spain

10.6.3.1.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.3.1.1.  Albumin

10.6.3.1.1.1.  Bovine Serum Albumin

10.6.3.1.1.2.  Human Serum Albumin

10.6.3.1.1.3.  Recombinant Human Serum Albumin

10.6.3.1.2.  Hormones

10.6.3.1.3.  Attachment Factors

10.6.3.1.4.  Amino Acid

10.6.3.1.5.  Growth factors and Cytokines

10.6.3.1.5.1.  Tumor Necrosis Factors

10.6.3.1.5.2.  Insulin-Like Growth Factors

10.6.3.1.5.3.  Interferons

10.6.3.1.5.4.  Interleukins

10.6.3.2.  Spain Market Revenue (US$ Mn) and Forecasts, By Type

10.6.3.2.1.  Chemically-Defined Media

10.6.3.2.2.  Classical Media

10.6.3.2.3.  Lysogeny Broth

10.6.3.2.4.  Protein-Free Media

10.6.3.2.5.  Serum-Free Media

10.6.3.2.6.  Specialty Media

10.6.3.3.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.3.3.1.  Biopharmaceuticals and Therapeutics

10.6.3.3.2.  Biotech Research

10.6.3.3.3.  Cancer

10.6.3.3.4.  Drug Screening and Drug Development

10.6.3.3.5.  Regenerative Medicine and Tissue Engineering

10.6.3.3.6.  Stem Cell Technologies

10.6.3.4.  Spain Market Revenue (US$ Mn) and Forecasts, By End User

10.6.3.4.1.  Biotechnology and Pharmaceutical Companies

10.6.3.4.2.  Research Laboratories

10.6.3.4.3.  Academic Institutes

10.6.3.4.4.  Pathology Labs

10.6.4. Germany

10.6.4.1.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.4.1.1.  Albumin

10.6.4.1.1.1.  Bovine Serum Albumin

10.6.4.1.1.2.  Human Serum Albumin

10.6.4.1.1.3.  Recombinant Human Serum Albumin

10.6.4.1.2.  Hormones

10.6.4.1.3.  Attachment Factors

10.6.4.1.4.  Amino Acid

10.6.4.1.5.  Growth factors and Cytokines

10.6.4.1.5.1.  Tumor Necrosis Factors

10.6.4.1.5.2.  Insulin-Like Growth Factors

10.6.4.1.5.3.  Interferons

10.6.4.1.5.4.  Interleukins

10.6.4.2.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.4.2.1.  Chemically-Defined Media

10.6.4.2.2.  Classical Media

10.6.4.2.3.  Lysogeny Broth

10.6.4.2.4.  Protein-Free Media

10.6.4.2.5.  Serum-Free Media

10.6.4.2.6.  Specialty Media

10.6.4.3.  Germany Market Revenue (US$ Mn) and Forecasts, By Application

10.6.4.3.1.  Biopharmaceuticals and Therapeutics

10.6.4.3.2.  Biotech Research

10.6.4.3.3.  Cancer

10.6.4.3.4.  Drug Screening and Drug Development

10.6.4.3.5.  Regenerative Medicine and Tissue Engineering

10.6.4.3.6.  Stem Cell Technologies

10.6.4.4.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.4.4.1.  Biotechnology and Pharmaceutical Companies

10.6.4.4.2.  Research Laboratories

10.6.4.4.3.  Academic Institutes

10.6.4.4.4.  Pathology Labs

10.6.5. Italy

10.6.5.1.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.5.1.1.  Albumin

10.6.5.1.1.1.  Bovine Serum Albumin

10.6.5.1.1.2.  Human Serum Albumin

10.6.5.1.1.3.  Recombinant Human Serum Albumin

10.6.5.1.2.  Hormones

10.6.5.1.3.  Attachment Factors

10.6.5.1.4.  Amino Acid

10.6.5.1.5.  Growth factors and Cytokines

10.6.5.1.5.1.  Tumor Necrosis Factors

10.6.5.1.5.2.  Insulin-Like Growth Factors

10.6.5.1.5.3.  Interferons

10.6.5.1.5.4.  Interleukins

10.6.5.2.  Italy Market Revenue (US$ Mn) and Forecasts, By Type

10.6.5.2.1.  Chemically-Defined Media

10.6.5.2.2.  Classical Media

10.6.5.2.3.  Lysogeny Broth

10.6.5.2.4.  Protein-Free Media

10.6.5.2.5.  Serum-Free Media

10.6.5.2.6.  Specialty Media

10.6.5.3.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.5.3.1.  Biopharmaceuticals and Therapeutics

10.6.5.3.2.  Biotech Research

10.6.5.3.3.  Cancer

10.6.5.3.4.  Drug Screening and Drug Development

10.6.5.3.5.  Regenerative Medicine and Tissue Engineering

10.6.5.3.6.  Stem Cell Technologies

10.6.5.4.  Italy Market Revenue (US$ Mn) and Forecasts, By End User

10.6.5.4.1.  Biotechnology and Pharmaceutical Companies

10.6.5.4.2.  Research Laboratories

10.6.5.4.3.  Academic Institutes

10.6.5.4.4.  Pathology Labs

10.6.6. Rest of Europe

10.6.6.1.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.6.1.1.  Albumin

10.6.6.1.1.1.  Bovine Serum Albumin

10.6.6.1.1.2.  Human Serum Albumin

10.6.6.1.1.3.  Recombinant Human Serum Albumin

10.6.6.1.2.  Hormones

10.6.6.1.3.  Attachment Factors

10.6.6.1.4.  Amino Acid

10.6.6.1.5.  Growth factors and Cytokines

10.6.6.1.5.1.  Tumor Necrosis Factors

10.6.6.1.5.2.  Insulin-Like Growth Factors

10.6.6.1.5.3.  Interferons

10.6.6.1.5.4.  Interleukins

10.6.6.2.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.6.2.1.  Chemically-Defined Media

10.6.6.2.2.  Classical Media

10.6.6.2.3.  Lysogeny Broth

10.6.6.2.4.  Protein-Free Media

10.6.6.2.5.  Serum-Free Media

10.6.6.2.6.  Specialty Media

10.6.6.3.  Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.6.6.3.1.  Biopharmaceuticals and Therapeutics

10.6.6.3.2.  Biotech Research

10.6.6.3.3.  Cancer

10.6.6.3.4.  Drug Screening and Drug Development

10.6.6.3.5.  Regenerative Medicine and Tissue Engineering

10.6.6.3.6.  Stem Cell Technologies

10.6.6.4.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.6.4.1.  Biotechnology and Pharmaceutical Companies

10.6.6.4.2.  Research Laboratories

10.6.6.4.3.  Academic Institutes

10.6.6.4.4.  Pathology Labs

10.7. Key Segment for Channeling Investments

10.7.1. By Country

10.7.2. By Reagent Type

10.7.3. By Type

10.7.4. By Application

10.7.5. By End User

11. Asia Pacific Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Asia Pacific Market Revenue (US$ Mn)

11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.2.1. Albumin

11.2.1.1.  Bovine Serum Albumin

11.2.1.2.  Human Serum Albumin

11.2.1.3.  Recombinant Human Serum Albumin

11.2.2. Hormones

11.2.3. Attachment Factors

11.2.4. Amino Acid

11.2.5. Growth factors and Cytokines

11.2.5.1.  Tumor Necrosis Factors

11.2.5.2.  Insulin-Like Growth Factors

11.2.5.3.  Interferons

11.2.5.4.  Interleukins

11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.3.1. Chemically-Defined Media

11.3.2. Classical Media

11.3.3. Lysogeny Broth

11.3.4. Protein-Free Media

11.3.5. Serum-Free Media

11.3.6. Specialty Media

11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1. Biopharmaceuticals and Therapeutics

11.4.2. Biotech Research

11.4.3. Cancer

11.4.4. Drug Screening and Drug Development

11.4.5. Regenerative Medicine and Tissue Engineering

11.4.6. Stem Cell Technologies

11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.5.1. Biotechnology and Pharmaceutical Companies

11.5.2. Research Laboratories

11.5.3. Academic Institutes

11.5.4. Pathology Labs

11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country

11.6.1. China

11.6.1.1.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.1.1.1.  Albumin

11.6.1.1.1.1.  Bovine Serum Albumin

11.6.1.1.1.2.  Human Serum Albumin

11.6.1.1.1.3.  Recombinant Human Serum Albumin

11.6.1.1.2.  Hormones

11.6.1.1.3.  Attachment Factors

11.6.1.1.4.  Amino Acid

11.6.1.1.5.  Growth factors and Cytokines

11.6.1.1.5.1.  Tumor Necrosis Factors

11.6.1.1.5.2.  Insulin-Like Growth Factors

11.6.1.1.5.3.  Interferons

11.6.1.1.5.4.  Interleukins

11.6.1.2.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.1.2.1.  Chemically-Defined Media

11.6.1.2.2.  Classical Media

11.6.1.2.3.  Lysogeny Broth

11.6.1.2.4.  Protein-Free Media

11.6.1.2.5.  Serum-Free Media

11.6.1.2.6.  Specialty Media

11.6.1.3.  China Market Revenue (US$ Mn) and Forecasts, By Application

11.6.1.3.1.  Biopharmaceuticals and Therapeutics

11.6.1.3.2.  Biotech Research

11.6.1.3.3.  Cancer

11.6.1.3.4.  Drug Screening and Drug Development

11.6.1.3.5.  Regenerative Medicine and Tissue Engineering

11.6.1.3.6.  Stem Cell Technologies

11.6.1.4.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.1.4.1.  Biotechnology and Pharmaceutical Companies

11.6.1.4.2.  Research Laboratories

11.6.1.4.3.  Academic Institutes

11.6.1.4.4.  Pathology Labs

11.6.2. Japan

11.6.2.1.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.2.1.1.  Albumin

11.6.2.1.1.1.  Bovine Serum Albumin

11.6.2.1.1.2.  Human Serum Albumin

11.6.2.1.1.3.  Recombinant Human Serum Albumin

11.6.2.1.2.  Hormones

11.6.2.1.3.  Attachment Factors

11.6.2.1.4.  Amino Acid

11.6.2.1.5.  Growth factors and Cytokines

11.6.2.1.5.1.  Tumor Necrosis Factors

11.6.2.1.5.2.  Insulin-Like Growth Factors

11.6.2.1.5.3.  Interferons

11.6.2.1.5.4.  Interleukins

11.6.2.2.  Japan Market Revenue (US$ Mn) and Forecasts, By Type

11.6.2.2.1.  Chemically-Defined Media

11.6.2.2.2.  Classical Media

11.6.2.2.3.  Lysogeny Broth

11.6.2.2.4.  Protein-Free Media

11.6.2.2.5.  Serum-Free Media

11.6.2.2.6.  Specialty Media

11.6.2.3.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.2.3.1.  Biopharmaceuticals and Therapeutics

11.6.2.3.2.  Biotech Research

11.6.2.3.3.  Cancer

11.6.2.3.4.  Drug Screening and Drug Development

11.6.2.3.5.  Regenerative Medicine and Tissue Engineering

11.6.2.3.6.  Stem Cell Technologies

11.6.2.4.  Japan Market Revenue (US$ Mn) and Forecasts, By End User

11.6.2.4.1.  Biotechnology and Pharmaceutical Companies

11.6.2.4.2.  Research Laboratories

11.6.2.4.3.  Academic Institutes

11.6.2.4.4.  Pathology Labs

11.6.3. India

11.6.3.1.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.3.1.1.  Albumin

11.6.3.1.1.1.  Bovine Serum Albumin

11.6.3.1.1.2.  Human Serum Albumin

11.6.3.1.1.3.  Recombinant Human Serum Albumin

11.6.3.1.2.  Hormones

11.6.3.1.3.  Attachment Factors

11.6.3.1.4.  Amino Acid

11.6.3.1.5.  Growth factors and Cytokines

11.6.3.1.5.1.  Tumor Necrosis Factors

11.6.3.1.5.2.  Insulin-Like Growth Factors

11.6.3.1.5.3.  Interferons

11.6.3.1.5.4.  Interleukins

11.6.3.2.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.3.2.1.  Chemically-Defined Media

11.6.3.2.2.  Classical Media

11.6.3.2.3.  Lysogeny Broth

11.6.3.2.4.  Protein-Free Media

11.6.3.2.5.  Serum-Free Media

11.6.3.2.6.  Specialty Media

11.6.3.3.  India Market Revenue (US$ Mn) and Forecasts, By Application

11.6.3.3.1.  Biopharmaceuticals and Therapeutics

11.6.3.3.2.  Biotech Research

11.6.3.3.3.  Cancer

11.6.3.3.4.  Drug Screening and Drug Development

11.6.3.3.5.  Regenerative Medicine and Tissue Engineering

11.6.3.3.6.  Stem Cell Technologies

11.6.3.4.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.3.4.1.  Biotechnology and Pharmaceutical Companies

11.6.3.4.2.  Research Laboratories

11.6.3.4.3.  Academic Institutes

11.6.3.4.4.  Pathology Labs

11.6.4. Southeast Asia

11.6.4.1.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.4.1.1.  Albumin

11.6.4.1.1.1.  Bovine Serum Albumin

11.6.4.1.1.2.  Human Serum Albumin

11.6.4.1.1.3.  Recombinant Human Serum Albumin

11.6.4.1.2.  Hormones

11.6.4.1.3.  Attachment Factors

11.6.4.1.4.  Amino Acid

11.6.4.1.5.  Growth factors and Cytokines

11.6.4.1.5.1.  Tumor Necrosis Factors

11.6.4.1.5.2.  Insulin-Like Growth Factors

11.6.4.1.5.3.  Interferons

11.6.4.1.5.4.  Interleukins

11.6.4.2.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.4.2.1.  Chemically-Defined Media

11.6.4.2.2.  Classical Media

11.6.4.2.3.  Lysogeny Broth

11.6.4.2.4.  Protein-Free Media

11.6.4.2.5.  Serum-Free Media

11.6.4.2.6.  Specialty Media

11.6.4.3.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.4.3.1.  Biopharmaceuticals and Therapeutics

11.6.4.3.2.  Biotech Research

11.6.4.3.3.  Cancer

11.6.4.3.4.  Drug Screening and Drug Development

11.6.4.3.5.  Regenerative Medicine and Tissue Engineering

11.6.4.3.6.  Stem Cell Technologies

11.6.4.4.  Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End User

11.6.4.4.1.  Biotechnology and Pharmaceutical Companies

11.6.4.4.2.  Research Laboratories

11.6.4.4.3.  Academic Institutes

11.6.4.4.4.  Pathology Labs

11.6.5. Rest of Asia Pacific

11.6.5.1.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.5.1.1.  Albumin

11.6.5.1.1.1.  Bovine Serum Albumin

11.6.5.1.1.2.  Human Serum Albumin

11.6.5.1.1.3.  Recombinant Human Serum Albumin

11.6.5.1.2.  Hormones

11.6.5.1.3.  Attachment Factors

11.6.5.1.4.  Amino Acid

11.6.5.1.5.  Growth factors and Cytokines

11.6.5.1.5.1.  Tumor Necrosis Factors

11.6.5.1.5.2.  Insulin-Like Growth Factors

11.6.5.1.5.3.  Interferons

11.6.5.1.5.4.  Interleukins

11.6.5.2.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.5.2.1.  Chemically-Defined Media

11.6.5.2.2.  Classical Media

11.6.5.2.3.  Lysogeny Broth

11.6.5.2.4.  Protein-Free Media

11.6.5.2.5.  Serum-Free Media

11.6.5.2.6.  Specialty Media

11.6.5.3.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.5.3.1.  Biopharmaceuticals and Therapeutics

11.6.5.3.2.  Biotech Research

11.6.5.3.3.  Cancer

11.6.5.3.4.  Drug Screening and Drug Development

11.6.5.3.5.  Regenerative Medicine and Tissue Engineering

11.6.5.3.6.  Stem Cell Technologies

11.6.5.4.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.5.4.1.  Biotechnology and Pharmaceutical Companies

11.6.5.4.2.  Research Laboratories

11.6.5.4.3.  Academic Institutes

11.6.5.4.4.  Pathology Labs

11.7. Key Segment for Channeling Investments

11.7.1. By Country

11.7.2. By Reagent Type

11.7.3. By Type

11.7.4. By Application

11.7.5. By End User

12. Middle East and Africa Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Middle East and Africa Market Revenue (US$ Mn)

12.2. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.2.1. Albumin

12.2.1.1.  Bovine Serum Albumin

12.2.1.2.  Human Serum Albumin

12.2.1.3.  Recombinant Human Serum Albumin

12.2.2. Hormones

12.2.3. Attachment Factors

12.2.4. Amino Acid

12.2.5. Growth factors and Cytokines

12.2.5.1.  Tumor Necrosis Factors

12.2.5.2.  Insulin-Like Growth Factors

12.2.5.3.  Interferons

12.2.5.4.  Interleukins

12.3. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.3.1. Chemically-Defined Media

12.3.2. Classical Media

12.3.3. Lysogeny Broth

12.3.4. Protein-Free Media

12.3.5. Serum-Free Media

12.3.6. Specialty Media

12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Biopharmaceuticals and Therapeutics

12.4.2. Biotech Research

12.4.3. Cancer

12.4.4. Drug Screening and Drug Development

12.4.5. Regenerative Medicine and Tissue Engineering

12.4.6. Stem Cell Technologies

12.5. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1. Biotechnology and Pharmaceutical Companies

12.5.2. Research Laboratories

12.5.3. Academic Institutes

12.5.4. Pathology Labs

12.6. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. GCC Countries

12.6.1.1.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.1.1.1.  Albumin

12.6.1.1.1.1.  Bovine Serum Albumin

12.6.1.1.1.2.  Human Serum Albumin

12.6.1.1.1.3.  Recombinant Human Serum Albumin

12.6.1.1.2.  Hormones

12.6.1.1.3.  Attachment Factors

12.6.1.1.4.  Amino Acid

12.6.1.1.5.  Growth factors and Cytokines

12.6.1.1.5.1.  Tumor Necrosis Factors

12.6.1.1.5.2.  Insulin-Like Growth Factors

12.6.1.1.5.3.  Interferons

12.6.1.1.5.4.  Interleukins

12.6.1.2.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.1.2.1.  Chemically-Defined Media

12.6.1.2.2.  Classical Media

12.6.1.2.3.  Lysogeny Broth

12.6.1.2.4.  Protein-Free Media

12.6.1.2.5.  Serum-Free Media

12.6.1.2.6.  Specialty Media

12.6.1.3.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Biopharmaceuticals and Therapeutics

12.6.1.3.2.  Biotech Research

12.6.1.3.3.  Cancer

12.6.1.3.4.  Drug Screening and Drug Development

12.6.1.3.5.  Regenerative Medicine and Tissue Engineering

12.6.1.3.6.  Stem Cell Technologies

12.6.1.4.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.1.4.1.  Biotechnology and Pharmaceutical Companies

12.6.1.4.2.  Research Laboratories

12.6.1.4.3.  Academic Institutes

12.6.1.4.4.  Pathology Labs

12.6.2. Southern Africa

12.6.2.1.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.2.1.1.  Albumin

12.6.2.1.1.1.  Bovine Serum Albumin

12.6.2.1.1.2.  Human Serum Albumin

12.6.2.1.1.3.  Recombinant Human Serum Albumin

12.6.2.1.2.  Hormones

12.6.2.1.3.  Attachment Factors

12.6.2.1.4.  Amino Acid

12.6.2.1.5.  Growth factors and Cytokines

12.6.2.1.5.1.  Tumor Necrosis Factors

12.6.2.1.5.2.  Insulin-Like Growth Factors

12.6.2.1.5.3.  Interferons

12.6.2.1.5.4.  Interleukins

12.6.2.2.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type

12.6.2.2.1.  Chemically-Defined Media

12.6.2.2.2.  Classical Media

12.6.2.2.3.  Lysogeny Broth

12.6.2.2.4.  Protein-Free Media

12.6.2.2.5.  Serum-Free Media

12.6.2.2.6.  Specialty Media

12.6.2.3.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Biopharmaceuticals and Therapeutics

12.6.2.3.2.  Biotech Research

12.6.2.3.3.  Cancer

12.6.2.3.4.  Drug Screening and Drug Development

12.6.2.3.5.  Regenerative Medicine and Tissue Engineering

12.6.2.3.6.  Stem Cell Technologies

12.6.2.4.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By End User

12.6.2.4.1.  Biotechnology and Pharmaceutical Companies

12.6.2.4.2.  Research Laboratories

12.6.2.4.3.  Academic Institutes

12.6.2.4.4.  Pathology Labs

12.6.3. Rest of MEA

12.6.3.1.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.3.1.1.  Albumin

12.6.3.1.1.1.  Bovine Serum Albumin

12.6.3.1.1.2.  Human Serum Albumin

12.6.3.1.1.3.  Recombinant Human Serum Albumin

12.6.3.1.2.  Hormones

12.6.3.1.3.  Attachment Factors

12.6.3.1.4.  Amino Acid

12.6.3.1.5.  Growth factors and Cytokines

12.6.3.1.5.1.  Tumor Necrosis Factors

12.6.3.1.5.2.  Insulin-Like Growth Factors

12.6.3.1.5.3.  Interferons

12.6.3.1.5.4.  Interleukins

12.6.3.2.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.3.2.1.  Chemically-Defined Media

12.6.3.2.2.  Classical Media

12.6.3.2.3.  Lysogeny Broth

12.6.3.2.4.  Protein-Free Media

12.6.3.2.5.  Serum-Free Media

12.6.3.2.6.  Specialty Media

12.6.3.3.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Biopharmaceuticals and Therapeutics

12.6.3.3.2.  Biotech Research

12.6.3.3.3.  Cancer

12.6.3.3.4.  Drug Screening and Drug Development

12.6.3.3.5.  Regenerative Medicine and Tissue Engineering

12.6.3.3.6.  Stem Cell Technologies

12.6.3.4.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.3.4.1.  Biotechnology and Pharmaceutical Companies

12.6.3.4.2.  Research Laboratories

12.6.3.4.3.  Academic Institutes

12.6.3.4.4.  Pathology Labs

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Reagent Type

12.7.3. By Type

12.7.4. By Application

12.7.5. By End User

13. Latin America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Latin America Market Revenue (US$ Mn)

13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.2.1. Albumin

13.2.1.1.  Bovine Serum Albumin

13.2.1.2.  Human Serum Albumin

13.2.1.3.  Recombinant Human Serum Albumin

13.2.2. Hormones

13.2.3. Attachment Factors

13.2.4. Amino Acid

13.2.5. Growth factors and Cytokines

13.2.5.1.  Tumor Necrosis Factors

13.2.5.2.  Insulin-Like Growth Factors

13.2.5.3.  Interferons

13.2.5.4.  Interleukins

13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.3.1. Chemically-Defined Media

13.3.2. Classical Media

13.3.3. Lysogeny Broth

13.3.4. Protein-Free Media

13.3.5. Serum-Free Media

13.3.6. Specialty Media

13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Biopharmaceuticals and Therapeutics

13.4.2. Biotech Research

13.4.3. Cancer

13.4.4. Drug Screening and Drug Development

13.4.5. Regenerative Medicine and Tissue Engineering

13.4.6. Stem Cell Technologies

13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1. Biotechnology and Pharmaceutical Companies

13.5.2. Research Laboratories

13.5.3. Academic Institutes

13.5.4. Pathology Labs

13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. Brazil

13.6.1.1.  Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.6.1.1.1.  Albumin

13.6.1.1.1.1.  Bovine Serum Albumin

13.6.1.1.1.2.  Human Serum Albumin

13.6.1.1.1.3.  Recombinant Human Serum Albumin

13.6.1.1.2.  Hormones

13.6.1.1.3.  Attachment Factors

13.6.1.1.4.  Amino Acid

13.6.1.1.5.  Growth factors and Cytokines

13.6.1.1.5.1.  Tumor Necrosis Factors

13.6.1.1.5.2.  Insulin-Like Growth Factors

13.6.1.1.5.3.  Interferons

13.6.1.1.5.4.  Interleukins

13.6.1.2.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.6.1.2.1.  Chemically-Defined Media

13.6.1.2.2.  Classical Media

13.6.1.2.3.  Lysogeny Broth

13.6.1.2.4.  Protein-Free Media

13.6.1.2.5.  Serum-Free Media

13.6.1.2.6.  Specialty Media

13.6.1.3.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.3.1.  Biopharmaceuticals and Therapeutics

13.6.1.3.2.  Biotech Research

13.6.1.3.3.  Cancer

13.6.1.3.4.  Drug Screening and Drug Development

13.6.1.3.5.  Regenerative Medicine and Tissue Engineering

13.6.1.3.6.  Stem Cell Technologies

13.6.1.4.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.6.1.4.1.  Biotechnology and Pharmaceutical Companies

13.6.1.4.2.  Research Laboratories

13.6.1.4.3.  Academic Institutes

13.6.1.4.4.  Pathology Labs

13.6.2. Rest of Latin America

13.6.2.1.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.6.2.1.1.  Albumin

13.6.2.1.1.1.  Bovine Serum Albumin

13.6.2.1.1.2.  Human Serum Albumin

13.6.2.1.1.3.  Recombinant Human Serum Albumin

13.6.2.1.2.  Hormones

13.6.2.1.3.  Attachment Factors

13.6.2.1.4.  Amino Acid

13.6.2.1.5.  Growth factors and Cytokines

13.6.2.1.5.1.  Tumor Necrosis Factors

13.6.2.1.5.2.  Insulin-Like Growth Factors

13.6.2.1.5.3.  Interferons

13.6.2.1.5.4.  Interleukins

13.6.2.2.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.6.2.2.1.  Chemically-Defined Media

13.6.2.2.2.  Classical Media

13.6.2.2.3.  Lysogeny Broth

13.6.2.2.4.  Protein-Free Media

13.6.2.2.5.  Serum-Free Media

13.6.2.2.6.  Specialty Media

13.6.2.3.  Rest of Latin America Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.3.1.  Biopharmaceuticals and Therapeutics

13.6.2.3.2.  Biotech Research

13.6.2.3.3.  Cancer

13.6.2.3.4.  Drug Screening and Drug Development

13.6.2.3.5.  Regenerative Medicine and Tissue Engineering

13.6.2.3.6.  Stem Cell Technologies

13.6.2.4.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.6.2.4.1.  Biotechnology and Pharmaceutical Companies

13.6.2.4.2.  Research Laboratories

13.6.2.4.3.  Academic Institutes

13.6.2.4.4.  Pathology Labs

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Reagent Type

13.7.3. By Type

13.7.4. By Application

13.7.5. By End User

14. Competitive Benchmarking

14.1. Player Positioning Analysis

14.2. Global Presence and Growth Strategies

15. Player Profiles

15.1. Affymetrix, Inc.

15.1.1. Company Details

15.1.2. Company Overview

15.1.3. Product Offerings

15.1.4. Key Developments

15.1.5. Financial Analysis

15.1.6. SWOT Analysis

15.1.7. Business Strategies

15.2. Analytical Biological Services Inc.

15.2.1. Company Details

15.2.2. Company Overview

15.2.3. Product Offerings

15.2.4. Key Developments

15.2.5. Financial Analysis

15.2.6. SWOT Analysis

15.2.7. Business Strategies

15.3. BD Biosciences

15.3.1. Company Details

15.3.2. Company Overview

15.3.3. Product Offerings

15.3.4. Key Developments

15.3.5. Financial Analysis

15.3.6. SWOT Analysis

15.3.7. Business Strategies

15.4. Bio-Techne Corporation

15.4.1. Company Details

15.4.2. Company Overview

15.4.3. Product Offerings

15.4.4. Key Developments

15.4.5. Financial Analysis

15.4.6. SWOT Analysis

15.4.7. Business Strategies

15.5. Cell Essentials, Inc.

15.5.1. Company Details

15.5.2. Company Overview

15.5.3. Product Offerings

15.5.4. Key Developments

15.5.5. Financial Analysis

15.5.6. SWOT Analysis

15.5.7. Business Strategies

15.6. ClonTech Laboratories, Inc.

15.6.1. Company Details

15.6.2. Company Overview

15.6.3. Product Offerings

15.6.4. Key Developments

15.6.5. Financial Analysis

15.6.6. SWOT Analysis

15.6.7. Business Strategies

15.7. GE Healthcare

15.7.1. Company Details

15.7.2. Company Overview

15.7.3. Product Offerings

15.7.4. Key Developments

15.7.5. Financial Analysis

15.7.6. SWOT Analysis

15.7.7. Business Strategies

15.8. J R Scientific Inc.

15.8.1. Company Details

15.8.2. Company Overview

15.8.3. Product Offerings

15.8.4. Key Developments

15.8.5. Financial Analysis

15.8.6. SWOT Analysis

15.8.7. Business Strategies

15.9. Johnson & Johnson

15.9.1. Company Details

15.9.2. Company Overview

15.9.3. Product Offerings

15.9.4. Key Developments

15.9.5. Financial Analysis

15.9.6. SWOT Analysis

15.9.7. Business Strategies

15.10. Lonza

15.10.1.  Company Details

15.10.2.  Company Overview

15.10.3.  Product Offerings

15.10.4.  Key Developments

15.10.5.  Financial Analysis

15.10.6.  SWOT Analysis

15.10.7.  Business Strategies

15.11. Merck KGaA

15.11.1.  Company Details

15.11.2.  Company Overview

15.11.3.  Product Offerings

15.11.4.  Key Developments

15.11.5.  Financial Analysis

15.11.6.  SWOT Analysis

15.11.7.  Business Strategies

15.12. MP Biomedicals

15.12.1.  Company Details

15.12.2.  Company Overview

15.12.3.  Product Offerings

15.12.4.  Key Developments

15.12.5.  Financial Analysis

15.12.6.  SWOT Analysis

15.12.7.  Business Strategies

15.13. Novozymes A/S

15.13.1.  Company Details

15.13.2.  Company Overview

15.13.3.  Product Offerings

15.13.4.  Key Developments

15.13.5.  Financial Analysis

15.13.6.  SWOT Analysis

15.13.7.  Business Strategies

15.14. Quality Biological, Inc.

15.14.1.  Company Details

15.14.2.  Company Overview

15.14.3.  Product Offerings

15.14.4.  Key Developments

15.14.5.  Financial Analysis

15.14.6.  SWOT Analysis

15.14.7.  Business Strategies

15.15. SeraCare Life Sciences, Inc.

15.15.1.  Company Details

15.15.2.  Company Overview

15.15.3.  Product Offerings

15.15.4.  Key Developments

15.15.5.  Financial Analysis

15.15.6.  SWOT Analysis

15.15.7.  Business Strategies

15.16. SIAM Bioscience

15.16.1.  Company Details

15.16.2.  Company Overview

15.16.3.  Product Offerings

15.16.4.  Key Developments

15.16.5.  Financial Analysis

15.16.6.  SWOT Analysis

15.16.7.  Business Strategies

15.17. Stemcell Technologies Inc.

15.17.1.  Company Details

15.17.2.  Company Overview

15.17.3.  Product Offerings

15.17.4.  Key Developments

15.17.5.  Financial Analysis

15.17.6.  SWOT Analysis

15.17.7.  Business Strategies

15.18. Thermo Fisher Scientific, Inc.

15.18.1.  Company Details

15.18.2.  Company Overview

15.18.3.  Product Offerings

15.18.4.  Key Developments

15.18.5.  Financial Analysis

15.18.6.  SWOT Analysis

15.18.7.  Business Strategies

 

 

 Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Cell Culture Media Market Snapshot

3.    Executive Summary: Cell Culture Media Market

4.    Qualitative Analysis: Cell Culture Media Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

5.2.1.   Albumin (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin)

5.2.1.1.    Bovine Serum Albumin

5.2.1.2.    Human Serum Albumin

5.2.1.3.    Recombinant Human Serum Albumin

5.2.2.   Hormones

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.2.3.   Attachment Factors

5.2.3.1.    Definition

5.2.3.2.    Market Penetration

5.2.3.3.    Market Revenue Expected to Increase by 2026

5.2.3.4.    Compound Annual Growth Rate (CAGR)

5.2.4.   Amino Acid

5.2.4.1.    Definition

5.2.4.2.    Market Penetration

5.2.4.3.    Market Revenue Expected to Increase by 2026

5.2.4.4.    Compound Annual Growth Rate (CAGR)

5.2.5.   Growth factors and Cytokines (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Tumor Necrosis Factors, Insulin-Like Growth Factors, Interferons, Interleukins)

5.2.5.1.    Tumor Necrosis Factors

5.2.5.2.    Insulin-Like Growth Factors

5.2.5.3.    Interferons

5.2.5.4.    Interleukins

5.3.   Key Segment for Channeling Investments

5.3.1.   By Reagent Type

6.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Market Revenue (US$ Mn) and Forecasts, By Type

6.2.1.   Chemically-Defined Media

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Classical Media

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Lysogeny Broth

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.2.4.   Protein-Free Media

6.2.4.1.    Definition

6.2.4.2.    Market Penetration

6.2.4.3.    Market Revenue Expected to Increase by 2026

6.2.4.4.    Compound Annual Growth Rate (CAGR)

6.2.5.   Serum-Free Media

6.2.5.1.    Definition

6.2.5.2.    Market Penetration

6.2.5.3.    Market Revenue Expected to Increase by 2026

6.2.5.4.    Compound Annual Growth Rate (CAGR)

6.2.6.   Specialty Media

6.2.6.1.    Definition

6.2.6.2.    Market Penetration

6.2.6.3.    Market Revenue Expected to Increase by 2026

6.2.6.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Type

7.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

7.2.1.   Biopharmaceuticals and Therapeutics

7.2.1.1.    Definition

7.2.1.2.    Market Penetration

7.2.1.3.    Market Revenue Expected to Increase by 2026

7.2.1.4.    Compound Annual Growth Rate (CAGR)

7.2.2.   Biotech Research

7.2.2.1.    Definition

7.2.2.2.    Market Penetration

7.2.2.3.    Market Revenue Expected to Increase by 2026

7.2.2.4.    Compound Annual Growth Rate (CAGR)

7.2.3.   Cancer

7.2.3.1.    Definition

7.2.3.2.    Market Penetration

7.2.3.3.    Market Revenue Expected to Increase by 2026

7.2.3.4.    Compound Annual Growth Rate (CAGR)

7.2.4.   Drug Screening and Drug Development

7.2.4.1.    Definition

7.2.4.2.    Market Penetration

7.2.4.3.    Market Revenue Expected to Increase by 2026

7.2.4.4.    Compound Annual Growth Rate (CAGR)

7.2.5.   Regenerative Medicine and Tissue Engineering

7.2.5.1.    Definition

7.2.5.2.    Market Penetration

7.2.5.3.    Market Revenue Expected to Increase by 2026

7.2.5.4.    Compound Annual Growth Rate (CAGR)

7.2.6.   Stem Cell Technologies

7.2.6.1.    Definition

7.2.6.2.    Market Penetration

7.2.6.3.    Market Revenue Expected to Increase by 2026

7.2.6.4.    Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By Application

8.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.2.   Global Market Revenue (US$ Mn) and Forecasts, By End User

8.2.1.   Biotechnology and Pharmaceutical Companies

8.2.1.1.    Definition

8.2.1.2.    Market Penetration

8.2.1.3.    Market Revenue Expected to Increase by 2026

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.2.   Research Laboratories

8.2.2.1.    Definition

8.2.2.2.    Market Penetration

8.2.2.3.    Market Revenue Expected to Increase by 2026

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.3.   Academic Institutes

8.2.3.1.    Definition

8.2.3.2.    Market Penetration

8.2.3.3.    Market Revenue Expected to Increase by 2026

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.4.   Pathology Labs

8.2.4.1.    Definition

8.2.4.2.    Market Penetration

8.2.4.3.    Market Revenue Expected to Increase by 2026

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.3.   Key Segment for Channeling Investments

8.3.1.   By End User

9.    North America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   North America Market Revenue (US$ Mn)

9.2.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.2.1.   Albumin

9.2.1.1.    Bovine Serum Albumin

9.2.1.2.    Human Serum Albumin

9.2.1.3.    Recombinant Human Serum Albumin

9.2.2.   Hormones

9.2.3.   Attachment Factors

9.2.4.   Amino Acid

9.2.5.   Growth factors and Cytokines

9.2.5.1.    Tumor Necrosis Factors

9.2.5.2.    Insulin-Like Growth Factors

9.2.5.3.    Interferons

9.2.5.4.    Interleukins

9.3.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.3.1.   Chemically-Defined Media

9.3.2.   Classical Media

9.3.3.   Lysogeny Broth

9.3.4.   Protein-Free Media

9.3.5.   Serum-Free Media

9.3.6.   Specialty Media

9.4.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.   Biopharmaceuticals and Therapeutics

9.4.2.   Biotech Research

9.4.3.   Cancer

9.4.4.   Drug Screening and Drug Development

9.4.5.   Regenerative Medicine and Tissue Engineering

9.4.6.   Stem Cell Technologies

9.5.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.5.1.   Biotechnology and Pharmaceutical Companies

9.5.2.   Research Laboratories

9.5.3.   Academic Institutes

9.5.4.   Pathology Labs

9.6.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

9.6.1.   U.S.

9.6.1.1.    U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.1.1.1.    Albumin

9.6.1.1.1.1.  Bovine Serum Albumin

9.6.1.1.1.2.  Human Serum Albumin

9.6.1.1.1.3.  Recombinant Human Serum Albumin

9.6.1.1.2.    Hormones

9.6.1.1.3.    Attachment Factors

9.6.1.1.4.    Amino Acid

9.6.1.1.5.    Growth factors and Cytokines

9.6.1.1.5.1.  Tumor Necrosis Factors

9.6.1.1.5.2.  Insulin-Like Growth Factors

9.6.1.1.5.3.  Interferons

9.6.1.1.5.4.  Interleukins

9.6.1.2.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.1.2.1.    Chemically-Defined Media

9.6.1.2.2.    Classical Media

9.6.1.2.3.    Lysogeny Broth

9.6.1.2.4.    Protein-Free Media

9.6.1.2.5.    Serum-Free Media

9.6.1.2.6.    Specialty Media

9.6.1.3.    U.S. Market Revenue (US$ Mn) and Forecasts, By Application

9.6.1.3.1.    Biopharmaceuticals and Therapeutics

9.6.1.3.2.    Biotech Research

9.6.1.3.3.    Cancer

9.6.1.3.4.    Drug Screening and Drug Development

9.6.1.3.5.    Regenerative Medicine and Tissue Engineering

9.6.1.3.6.    Stem Cell Technologies

9.6.1.4.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.1.4.1.    Biotechnology and Pharmaceutical Companies

9.6.1.4.2.    Research Laboratories

9.6.1.4.3.    Academic Institutes

9.6.1.4.4.    Pathology Labs

9.6.2.   Rest of North America

9.6.2.1.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.2.1.1.    Albumin

9.6.2.1.1.1.  Bovine Serum Albumin

9.6.2.1.1.2.  Human Serum Albumin

9.6.2.1.1.3.  Recombinant Human Serum Albumin

9.6.2.1.2.    Hormones

9.6.2.1.3.    Attachment Factors

9.6.2.1.4.    Amino Acid

9.6.2.1.5.    Growth factors and Cytokines

9.6.2.1.5.1.  Tumor Necrosis Factors

9.6.2.1.5.2.  Insulin-Like Growth Factors

9.6.2.1.5.3.  Interferons

9.6.2.1.5.4.  Interleukins

9.6.2.2.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.2.2.1.    Chemically-Defined Media

9.6.2.2.2.    Classical Media

9.6.2.2.3.    Lysogeny Broth

9.6.2.2.4.    Protein-Free Media

9.6.2.2.5.    Serum-Free Media

9.6.2.2.6.    Specialty Media

9.6.2.3.    Rest of North America Market Revenue (US$ Mn) and Forecasts, By Application

9.6.2.3.1.    Biopharmaceuticals and Therapeutics

9.6.2.3.2.    Biotech Research

9.6.2.3.3.    Cancer

9.6.2.3.4.    Drug Screening and Drug Development

9.6.2.3.5.    Regenerative Medicine and Tissue Engineering

9.6.2.3.6.    Stem Cell Technologies

9.6.2.4.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.2.4.1.    Biotechnology and Pharmaceutical Companies

9.6.2.4.2.    Research Laboratories

9.6.2.4.3.    Academic Institutes

9.6.2.4.4.    Pathology Labs

9.7.   Key Segment for Channeling Investments

9.7.1.   By Country

9.7.2.   By Reagent Type

9.7.3.   By Type

9.7.4.   By Application

9.7.5.   By End User

10. Europe Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Europe Market Revenue (US$ Mn)

10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.2.1. Albumin

10.2.1.1.  Bovine Serum Albumin

10.2.1.2.  Human Serum Albumin

10.2.1.3.  Recombinant Human Serum Albumin

10.2.2. Hormones

10.2.3. Attachment Factors

10.2.4. Amino Acid

10.2.5. Growth factors and Cytokines

10.2.5.1.  Tumor Necrosis Factors

10.2.5.2.  Insulin-Like Growth Factors

10.2.5.3.  Interferons

10.2.5.4.  Interleukins

10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.3.1. Chemically-Defined Media

10.3.2. Classical Media

10.3.3. Lysogeny Broth

10.3.4. Protein-Free Media

10.3.5. Serum-Free Media

10.3.6. Specialty Media

10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1. Biopharmaceuticals and Therapeutics

10.4.2. Biotech Research

10.4.3. Cancer

10.4.4. Drug Screening and Drug Development

10.4.5. Regenerative Medicine and Tissue Engineering

10.4.6. Stem Cell Technologies

10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.5.1. Biotechnology and Pharmaceutical Companies

10.5.2. Research Laboratories

10.5.3. Academic Institutes

10.5.4. Pathology Labs

10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

10.6.1. France

10.6.1.1.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.1.1.1.  Albumin

10.6.1.1.1.1.  Bovine Serum Albumin

10.6.1.1.1.2.  Human Serum Albumin

10.6.1.1.1.3.  Recombinant Human Serum Albumin

10.6.1.1.2.  Hormones

10.6.1.1.3.  Attachment Factors

10.6.1.1.4.  Amino Acid

10.6.1.1.5.  Growth factors and Cytokines

10.6.1.1.5.1.  Tumor Necrosis Factors

10.6.1.1.5.2.  Insulin-Like Growth Factors

10.6.1.1.5.3.  Interferons

10.6.1.1.5.4.  Interleukins

10.6.1.2.  France Market Revenue (US$ Mn) and Forecasts, By Type

10.6.1.2.1.  Chemically-Defined Media

10.6.1.2.2.  Classical Media

10.6.1.2.3.  Lysogeny Broth

10.6.1.2.4.  Protein-Free Media

10.6.1.2.5.  Serum-Free Media

10.6.1.2.6.  Specialty Media

10.6.1.3.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.1.3.1.  Biopharmaceuticals and Therapeutics

10.6.1.3.2.  Biotech Research

10.6.1.3.3.  Cancer

10.6.1.3.4.  Drug Screening and Drug Development

10.6.1.3.5.  Regenerative Medicine and Tissue Engineering

10.6.1.3.6.  Stem Cell Technologies

10.6.1.4.  France Market Revenue (US$ Mn) and Forecasts, By End User

10.6.1.4.1.  Biotechnology and Pharmaceutical Companies

10.6.1.4.2.  Research Laboratories

10.6.1.4.3.  Academic Institutes

10.6.1.4.4.  Pathology Labs

10.6.2. The UK

10.6.2.1.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.2.1.1.  Albumin

10.6.2.1.1.1.  Bovine Serum Albumin

10.6.2.1.1.2.  Human Serum Albumin

10.6.2.1.1.3.  Recombinant Human Serum Albumin

10.6.2.1.2.  Hormones

10.6.2.1.3.  Attachment Factors

10.6.2.1.4.  Amino Acid

10.6.2.1.5.  Growth factors and Cytokines

10.6.2.1.5.1.  Tumor Necrosis Factors

10.6.2.1.5.2.  Insulin-Like Growth Factors

10.6.2.1.5.3.  Interferons

10.6.2.1.5.4.  Interleukins

10.6.2.2.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.2.2.1.  Chemically-Defined Media

10.6.2.2.2.  Classical Media

10.6.2.2.3.  Lysogeny Broth

10.6.2.2.4.  Protein-Free Media

10.6.2.2.5.  Serum-Free Media

10.6.2.2.6.  Specialty Media

10.6.2.3.  The UK Market Revenue (US$ Mn) and Forecasts, By Application

10.6.2.3.1.  Biopharmaceuticals and Therapeutics

10.6.2.3.2.  Biotech Research

10.6.2.3.3.  Cancer

10.6.2.3.4.  Drug Screening and Drug Development

10.6.2.3.5.  Regenerative Medicine and Tissue Engineering

10.6.2.3.6.  Stem Cell Technologies

10.6.2.4.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.2.4.1.  Biotechnology and Pharmaceutical Companies

10.6.2.4.2.  Research Laboratories

10.6.2.4.3.  Academic Institutes

10.6.2.4.4.  Pathology Labs

10.6.3. Spain

10.6.3.1.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.3.1.1.  Albumin

10.6.3.1.1.1.  Bovine Serum Albumin

10.6.3.1.1.2.  Human Serum Albumin

10.6.3.1.1.3.  Recombinant Human Serum Albumin

10.6.3.1.2.  Hormones

10.6.3.1.3.  Attachment Factors

10.6.3.1.4.  Amino Acid

10.6.3.1.5.  Growth factors and Cytokines

10.6.3.1.5.1.  Tumor Necrosis Factors

10.6.3.1.5.2.  Insulin-Like Growth Factors

10.6.3.1.5.3.  Interferons

10.6.3.1.5.4.  Interleukins

10.6.3.2.  Spain Market Revenue (US$ Mn) and Forecasts, By Type

10.6.3.2.1.  Chemically-Defined Media

10.6.3.2.2.  Classical Media

10.6.3.2.3.  Lysogeny Broth

10.6.3.2.4.  Protein-Free Media

10.6.3.2.5.  Serum-Free Media

10.6.3.2.6.  Specialty Media

10.6.3.3.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.3.3.1.  Biopharmaceuticals and Therapeutics

10.6.3.3.2.  Biotech Research

10.6.3.3.3.  Cancer

10.6.3.3.4.  Drug Screening and Drug Development

10.6.3.3.5.  Regenerative Medicine and Tissue Engineering

10.6.3.3.6.  Stem Cell Technologies

10.6.3.4.  Spain Market Revenue (US$ Mn) and Forecasts, By End User

10.6.3.4.1.  Biotechnology and Pharmaceutical Companies

10.6.3.4.2.  Research Laboratories

10.6.3.4.3.  Academic Institutes

10.6.3.4.4.  Pathology Labs

10.6.4. Germany

10.6.4.1.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.4.1.1.  Albumin

10.6.4.1.1.1.  Bovine Serum Albumin

10.6.4.1.1.2.  Human Serum Albumin

10.6.4.1.1.3.  Recombinant Human Serum Albumin

10.6.4.1.2.  Hormones

10.6.4.1.3.  Attachment Factors

10.6.4.1.4.  Amino Acid

10.6.4.1.5.  Growth factors and Cytokines

10.6.4.1.5.1.  Tumor Necrosis Factors

10.6.4.1.5.2.  Insulin-Like Growth Factors

10.6.4.1.5.3.  Interferons

10.6.4.1.5.4.  Interleukins

10.6.4.2.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.4.2.1.  Chemically-Defined Media

10.6.4.2.2.  Classical Media

10.6.4.2.3.  Lysogeny Broth

10.6.4.2.4.  Protein-Free Media

10.6.4.2.5.  Serum-Free Media

10.6.4.2.6.  Specialty Media

10.6.4.3.  Germany Market Revenue (US$ Mn) and Forecasts, By Application

10.6.4.3.1.  Biopharmaceuticals and Therapeutics

10.6.4.3.2.  Biotech Research

10.6.4.3.3.  Cancer

10.6.4.3.4.  Drug Screening and Drug Development

10.6.4.3.5.  Regenerative Medicine and Tissue Engineering

10.6.4.3.6.  Stem Cell Technologies

10.6.4.4.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.4.4.1.  Biotechnology and Pharmaceutical Companies

10.6.4.4.2.  Research Laboratories

10.6.4.4.3.  Academic Institutes

10.6.4.4.4.  Pathology Labs

10.6.5. Italy

10.6.5.1.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.5.1.1.  Albumin

10.6.5.1.1.1.  Bovine Serum Albumin

10.6.5.1.1.2.  Human Serum Albumin

10.6.5.1.1.3.  Recombinant Human Serum Albumin

10.6.5.1.2.  Hormones

10.6.5.1.3.  Attachment Factors

10.6.5.1.4.  Amino Acid

10.6.5.1.5.  Growth factors and Cytokines

10.6.5.1.5.1.  Tumor Necrosis Factors

10.6.5.1.5.2.  Insulin-Like Growth Factors

10.6.5.1.5.3.  Interferons

10.6.5.1.5.4.  Interleukins

10.6.5.2.  Italy Market Revenue (US$ Mn) and Forecasts, By Type

10.6.5.2.1.  Chemically-Defined Media

10.6.5.2.2.  Classical Media

10.6.5.2.3.  Lysogeny Broth

10.6.5.2.4.  Protein-Free Media

10.6.5.2.5.  Serum-Free Media

10.6.5.2.6.  Specialty Media

10.6.5.3.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.5.3.1.  Biopharmaceuticals and Therapeutics

10.6.5.3.2.  Biotech Research

10.6.5.3.3.  Cancer

10.6.5.3.4.  Drug Screening and Drug Development

10.6.5.3.5.  Regenerative Medicine and Tissue Engineering

10.6.5.3.6.  Stem Cell Technologies

10.6.5.4.  Italy Market Revenue (US$ Mn) and Forecasts, By End User

10.6.5.4.1.  Biotechnology and Pharmaceutical Companies

10.6.5.4.2.  Research Laboratories

10.6.5.4.3.  Academic Institutes

10.6.5.4.4.  Pathology Labs

10.6.6. Rest of Europe

10.6.6.1.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.6.1.1.  Albumin

10.6.6.1.1.1.  Bovine Serum Albumin

10.6.6.1.1.2.  Human Serum Albumin

10.6.6.1.1.3.  Recombinant Human Serum Albumin

10.6.6.1.2.  Hormones

10.6.6.1.3.  Attachment Factors

10.6.6.1.4.  Amino Acid

10.6.6.1.5.  Growth factors and Cytokines

10.6.6.1.5.1.  Tumor Necrosis Factors

10.6.6.1.5.2.  Insulin-Like Growth Factors

10.6.6.1.5.3.  Interferons

10.6.6.1.5.4.  Interleukins

10.6.6.2.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.6.2.1.  Chemically-Defined Media

10.6.6.2.2.  Classical Media

10.6.6.2.3.  Lysogeny Broth

10.6.6.2.4.  Protein-Free Media

10.6.6.2.5.  Serum-Free Media

10.6.6.2.6.  Specialty Media

10.6.6.3.  Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.6.6.3.1.  Biopharmaceuticals and Therapeutics

10.6.6.3.2.  Biotech Research

10.6.6.3.3.  Cancer

10.6.6.3.4.  Drug Screening and Drug Development

10.6.6.3.5.  Regenerative Medicine and Tissue Engineering

10.6.6.3.6.  Stem Cell Technologies

10.6.6.4.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.6.4.1.  Biotechnology and Pharmaceutical Companies

10.6.6.4.2.  Research Laboratories

10.6.6.4.3.  Academic Institutes

10.6.6.4.4.  Pathology Labs

10.7. Key Segment for Channeling Investments

10.7.1. By Country

10.7.2. By Reagent Type

10.7.3. By Type

10.7.4. By Application

10.7.5. By End User

11. Asia Pacific Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Asia Pacific Market Revenue (US$ Mn)

11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.2.1. Albumin

11.2.1.1.  Bovine Serum Albumin

11.2.1.2.  Human Serum Albumin

11.2.1.3.  Recombinant Human Serum Albumin

11.2.2. Hormones

11.2.3. Attachment Factors

11.2.4. Amino Acid

11.2.5. Growth factors and Cytokines

11.2.5.1.  Tumor Necrosis Factors

11.2.5.2.  Insulin-Like Growth Factors

11.2.5.3.  Interferons

11.2.5.4.  Interleukins

11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.3.1. Chemically-Defined Media

11.3.2. Classical Media

11.3.3. Lysogeny Broth

11.3.4. Protein-Free Media

11.3.5. Serum-Free Media

11.3.6. Specialty Media

11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1. Biopharmaceuticals and Therapeutics

11.4.2. Biotech Research

11.4.3. Cancer

11.4.4. Drug Screening and Drug Development

11.4.5. Regenerative Medicine and Tissue Engineering

11.4.6. Stem Cell Technologies

11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.5.1. Biotechnology and Pharmaceutical Companies

11.5.2. Research Laboratories

11.5.3. Academic Institutes

11.5.4. Pathology Labs

11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country

11.6.1. China

11.6.1.1.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.1.1.1.  Albumin

11.6.1.1.1.1.  Bovine Serum Albumin

11.6.1.1.1.2.  Human Serum Albumin

11.6.1.1.1.3.  Recombinant Human Serum Albumin

11.6.1.1.2.  Hormones

11.6.1.1.3.  Attachment Factors

11.6.1.1.4.  Amino Acid

11.6.1.1.5.  Growth factors and Cytokines

11.6.1.1.5.1.  Tumor Necrosis Factors

11.6.1.1.5.2.  Insulin-Like Growth Factors

11.6.1.1.5.3.  Interferons

11.6.1.1.5.4.  Interleukins

11.6.1.2.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.1.2.1.  Chemically-Defined Media

11.6.1.2.2.  Classical Media

11.6.1.2.3.  Lysogeny Broth

11.6.1.2.4.  Protein-Free Media

11.6.1.2.5.  Serum-Free Media

11.6.1.2.6.  Specialty Media

11.6.1.3.  China Market Revenue (US$ Mn) and Forecasts, By Application

11.6.1.3.1.  Biopharmaceuticals and Therapeutics

11.6.1.3.2.  Biotech Research

11.6.1.3.3.  Cancer

11.6.1.3.4.  Drug Screening and Drug Development

11.6.1.3.5.  Regenerative Medicine and Tissue Engineering

11.6.1.3.6.  Stem Cell Technologies

11.6.1.4.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.1.4.1.  Biotechnology and Pharmaceutical Companies

11.6.1.4.2.  Research Laboratories

11.6.1.4.3.  Academic Institutes

11.6.1.4.4.  Pathology Labs

11.6.2. Japan

11.6.2.1.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.2.1.1.  Albumin

11.6.2.1.1.1.  Bovine Serum Albumin

11.6.2.1.1.2.  Human Serum Albumin

11.6.2.1.1.3.  Recombinant Human Serum Albumin

11.6.2.1.2.  Hormones

11.6.2.1.3.  Attachment Factors

11.6.2.1.4.  Amino Acid

11.6.2.1.5.  Growth factors and Cytokines

11.6.2.1.5.1.  Tumor Necrosis Factors

11.6.2.1.5.2.  Insulin-Like Growth Factors

11.6.2.1.5.3.  Interferons

11.6.2.1.5.4.  Interleukins

11.6.2.2.  Japan Market Revenue (US$ Mn) and Forecasts, By Type

11.6.2.2.1.  Chemically-Defined Media

11.6.2.2.2.  Classical Media

11.6.2.2.3.  Lysogeny Broth

11.6.2.2.4.  Protein-Free Media

11.6.2.2.5.  Serum-Free Media

11.6.2.2.6.  Specialty Media

11.6.2.3.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.2.3.1.  Biopharmaceuticals and Therapeutics

11.6.2.3.2.  Biotech Research

11.6.2.3.3.  Cancer

11.6.2.3.4.  Drug Screening and Drug Development

11.6.2.3.5.  Regenerative Medicine and Tissue Engineering

11.6.2.3.6.  Stem Cell Technologies

11.6.2.4.  Japan Market Revenue (US$ Mn) and Forecasts, By End User

11.6.2.4.1.  Biotechnology and Pharmaceutical Companies

11.6.2.4.2.  Research Laboratories

11.6.2.4.3.  Academic Institutes

11.6.2.4.4.  Pathology Labs

11.6.3. India

11.6.3.1.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.3.1.1.  Albumin

11.6.3.1.1.1.  Bovine Serum Albumin

11.6.3.1.1.2.  Human Serum Albumin

11.6.3.1.1.3.  Recombinant Human Serum Albumin

11.6.3.1.2.  Hormones

11.6.3.1.3.  Attachment Factors

11.6.3.1.4.  Amino Acid

11.6.3.1.5.  Growth factors and Cytokines

11.6.3.1.5.1.  Tumor Necrosis Factors

11.6.3.1.5.2.  Insulin-Like Growth Factors

11.6.3.1.5.3.  Interferons

11.6.3.1.5.4.  Interleukins

11.6.3.2.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.3.2.1.  Chemically-Defined Media

11.6.3.2.2.  Classical Media

11.6.3.2.3.  Lysogeny Broth

11.6.3.2.4.  Protein-Free Media

11.6.3.2.5.  Serum-Free Media

11.6.3.2.6.  Specialty Media

11.6.3.3.  India Market Revenue (US$ Mn) and Forecasts, By Application

11.6.3.3.1.  Biopharmaceuticals and Therapeutics

11.6.3.3.2.  Biotech Research

11.6.3.3.3.  Cancer

11.6.3.3.4.  Drug Screening and Drug Development

11.6.3.3.5.  Regenerative Medicine and Tissue Engineering

11.6.3.3.6.  Stem Cell Technologies

11.6.3.4.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.3.4.1.  Biotechnology and Pharmaceutical Companies

11.6.3.4.2.  Research Laboratories

11.6.3.4.3.  Academic Institutes

11.6.3.4.4.  Pathology Labs

11.6.4. Southeast Asia

11.6.4.1.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.4.1.1.  Albumin

11.6.4.1.1.1.  Bovine Serum Albumin

11.6.4.1.1.2.  Human Serum Albumin

11.6.4.1.1.3.  Recombinant Human Serum Albumin

11.6.4.1.2.  Hormones

11.6.4.1.3.  Attachment Factors

11.6.4.1.4.  Amino Acid

11.6.4.1.5.  Growth factors and Cytokines

11.6.4.1.5.1.  Tumor Necrosis Factors

11.6.4.1.5.2.  Insulin-Like Growth Factors

11.6.4.1.5.3.  Interferons

11.6.4.1.5.4.  Interleukins

11.6.4.2.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.4.2.1.  Chemically-Defined Media

11.6.4.2.2.  Classical Media

11.6.4.2.3.  Lysogeny Broth

11.6.4.2.4.  Protein-Free Media

11.6.4.2.5.  Serum-Free Media

11.6.4.2.6.  Specialty Media

11.6.4.3.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.4.3.1.  Biopharmaceuticals and Therapeutics

11.6.4.3.2.  Biotech Research

11.6.4.3.3.  Cancer

11.6.4.3.4.  Drug Screening and Drug Development

11.6.4.3.5.  Regenerative Medicine and Tissue Engineering

11.6.4.3.6.  Stem Cell Technologies

11.6.4.4.  Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End User

11.6.4.4.1.  Biotechnology and Pharmaceutical Companies

11.6.4.4.2.  Research Laboratories

11.6.4.4.3.  Academic Institutes

11.6.4.4.4.  Pathology Labs

11.6.5. Rest of Asia Pacific

11.6.5.1.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.5.1.1.  Albumin

11.6.5.1.1.1.  Bovine Serum Albumin

11.6.5.1.1.2.  Human Serum Albumin

11.6.5.1.1.3.  Recombinant Human Serum Albumin

11.6.5.1.2.  Hormones

11.6.5.1.3.  Attachment Factors

11.6.5.1.4.  Amino Acid

11.6.5.1.5.  Growth factors and Cytokines

11.6.5.1.5.1.  Tumor Necrosis Factors

11.6.5.1.5.2.  Insulin-Like Growth Factors

11.6.5.1.5.3.  Interferons

11.6.5.1.5.4.  Interleukins

11.6.5.2.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.5.2.1.  Chemically-Defined Media

11.6.5.2.2.  Classical Media

11.6.5.2.3.  Lysogeny Broth

11.6.5.2.4.  Protein-Free Media

11.6.5.2.5.  Serum-Free Media

11.6.5.2.6.  Specialty Media

11.6.5.3.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.5.3.1.  Biopharmaceuticals and Therapeutics

11.6.5.3.2.  Biotech Research

11.6.5.3.3.  Cancer

11.6.5.3.4.  Drug Screening and Drug Development

11.6.5.3.5.  Regenerative Medicine and Tissue Engineering

11.6.5.3.6.  Stem Cell Technologies

11.6.5.4.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.5.4.1.  Biotechnology and Pharmaceutical Companies

11.6.5.4.2.  Research Laboratories

11.6.5.4.3.  Academic Institutes

11.6.5.4.4.  Pathology Labs

11.7. Key Segment for Channeling Investments

11.7.1. By Country

11.7.2. By Reagent Type

11.7.3. By Type

11.7.4. By Application

11.7.5. By End User

12. Middle East and Africa Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Middle East and Africa Market Revenue (US$ Mn)

12.2. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.2.1. Albumin

12.2.1.1.  Bovine Serum Albumin

12.2.1.2.  Human Serum Albumin

12.2.1.3.  Recombinant Human Serum Albumin

12.2.2. Hormones

12.2.3. Attachment Factors

12.2.4. Amino Acid

12.2.5. Growth factors and Cytokines

12.2.5.1.  Tumor Necrosis Factors

12.2.5.2.  Insulin-Like Growth Factors

12.2.5.3.  Interferons

12.2.5.4.  Interleukins

12.3. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.3.1. Chemically-Defined Media

12.3.2. Classical Media

12.3.3. Lysogeny Broth

12.3.4. Protein-Free Media

12.3.5. Serum-Free Media

12.3.6. Specialty Media

12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Biopharmaceuticals and Therapeutics

12.4.2. Biotech Research

12.4.3. Cancer

12.4.4. Drug Screening and Drug Development

12.4.5. Regenerative Medicine and Tissue Engineering

12.4.6. Stem Cell Technologies

12.5. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1. Biotechnology and Pharmaceutical Companies

12.5.2. Research Laboratories

12.5.3. Academic Institutes

12.5.4. Pathology Labs

12.6. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. GCC Countries

12.6.1.1.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.1.1.1.  Albumin

12.6.1.1.1.1.  Bovine Serum Albumin

12.6.1.1.1.2.  Human Serum Albumin

12.6.1.1.1.3.  Recombinant Human Serum Albumin

12.6.1.1.2.  Hormones

12.6.1.1.3.  Attachment Factors

12.6.1.1.4.  Amino Acid

12.6.1.1.5.  Growth factors and Cytokines

12.6.1.1.5.1.  Tumor Necrosis Factors

12.6.1.1.5.2.  Insulin-Like Growth Factors

12.6.1.1.5.3.  Interferons

12.6.1.1.5.4.  Interleukins

12.6.1.2.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.1.2.1.  Chemically-Defined Media

12.6.1.2.2.  Classical Media

12.6.1.2.3.  Lysogeny Broth

12.6.1.2.4.  Protein-Free Media

12.6.1.2.5.  Serum-Free Media

12.6.1.2.6.  Specialty Media

12.6.1.3.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Biopharmaceuticals and Therapeutics

12.6.1.3.2.  Biotech Research

12.6.1.3.3.  Cancer

12.6.1.3.4.  Drug Screening and Drug Development

12.6.1.3.5.  Regenerative Medicine and Tissue Engineering

12.6.1.3.6.  Stem Cell Technologies

12.6.1.4.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.1.4.1.  Biotechnology and Pharmaceutical Companies

12.6.1.4.2.  Research Laboratories

12.6.1.4.3.  Academic Institutes

12.6.1.4.4.  Pathology Labs

12.6.2. Southern Africa

12.6.2.1.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.2.1.1.  Albumin

12.6.2.1.1.1.  Bovine Serum Albumin

12.6.2.1.1.2.  Human Serum Albumin

12.6.2.1.1.3.  Recombinant Human Serum Albumin

12.6.2.1.2.  Hormones

12.6.2.1.3.  Attachment Factors

12.6.2.1.4.  Amino Acid

12.6.2.1.5.  Growth factors and Cytokines

12.6.2.1.5.1.  Tumor Necrosis Factors

12.6.2.1.5.2.  Insulin-Like Growth Factors

12.6.2.1.5.3.  Interferons

12.6.2.1.5.4.  Interleukins

12.6.2.2.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type

12.6.2.2.1.  Chemically-Defined Media

12.6.2.2.2.  Classical Media

12.6.2.2.3.  Lysogeny Broth

12.6.2.2.4.  Protein-Free Media

12.6.2.2.5.  Serum-Free Media

12.6.2.2.6.  Specialty Media

12.6.2.3.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Biopharmaceuticals and Therapeutics

12.6.2.3.2.  Biotech Research

12.6.2.3.3.  Cancer

12.6.2.3.4.  Drug Screening and Drug Development

12.6.2.3.5.  Regenerative Medicine and Tissue Engineering

12.6.2.3.6.  Stem Cell Technologies

12.6.2.4.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By End User

12.6.2.4.1.  Biotechnology and Pharmaceutical Companies

12.6.2.4.2.  Research Laboratories

12.6.2.4.3.  Academic Institutes

12.6.2.4.4.  Pathology Labs

12.6.3. Rest of MEA

12.6.3.1.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.3.1.1.  Albumin

12.6.3.1.1.1.  Bovine Serum Albumin

12.6.3.1.1.2.  Human Serum Albumin

12.6.3.1.1.3.  Recombinant Human Serum Albumin

12.6.3.1.2.  Hormones

12.6.3.1.3.  Attachment Factors

12.6.3.1.4.  Amino Acid

12.6.3.1.5.  Growth factors and Cytokines

12.6.3.1.5.1.  Tumor Necrosis Factors

12.6.3.1.5.2.  Insulin-Like Growth Factors

12.6.3.1.5.3.  Interferons

12.6.3.1.5.4.  Interleukins

12.6.3.2.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.3.2.1.  Chemically-Defined Media

12.6.3.2.2.  Classical Media

12.6.3.2.3.  Lysogeny Broth

12.6.3.2.4.  Protein-Free Media

12.6.3.2.5.  Serum-Free Media

12.6.3.2.6.  Specialty Media

12.6.3.3.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Biopharmaceuticals and Therapeutics

12.6.3.3.2.  Biotech Research

12.6.3.3.3.  Cancer

12.6.3.3.4.  Drug Screening and Drug Development

12.6.3.3.5.  Regenerative Medicine and Tissue Engineering

12.6.3.3.6.  Stem Cell Technologies

12.6.3.4.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.3.4.1.  Biotechnology and Pharmaceutical Companies

12.6.3.4.2.  Research Laboratories

12.6.3.4.3.  Academic Institutes

12.6.3.4.4.  Pathology Labs

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Reagent Type

12.7.3. By Type

12.7.4. By Application

12.7.5. By End User

13. Latin America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Latin America Market Revenue (US$ Mn)

13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.2.1. Albumin

13.2.1.1.  Bovine Serum Albumin

13.2.1.2.  Human Serum Albumin

13.2.1.3.  Recombinant Human Serum Albumin

13.2.2. Hormones

13.2.3. Attachment Factors

13.2.4. Amino Acid

13.2.5. Growth factors and Cytokines

13.2.5.1.  Tumor Necrosis Factors

13.2.5.2.  Insulin-Like Growth Factors

13.2.5.3.  Interferons

13.2.5.4.  Interleukins

13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.3.1. Chemically-Defined Media

13.3.2. Classical Media

13.3.3. Lysogeny Broth

13.3.4. Protein-Free Media

13.3.5. Serum-Free Media

13.3.6. Specialty Media

13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Biopharmaceuticals and Therapeutics

13.4.2. Biotech Research

13.4.3. Cancer

13.4.4. Drug Screening and Drug Development

13.4.5. Regenerative Medicine and Tissue Engineering

13.4.6. Stem Cell Technologies

13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1. Biotechnology and Pharmaceutical Companies

13.5.2. Research Laboratories

13.5.3. Academic Institutes

13.5.4. Pathology Labs

13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. Brazil

13.6.1.1.  Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.6.1.1.1.  Albumin

13.6.1.1.1.1.  Bovine Serum Albumin

13.6.1.1.1.2.  Human Serum Albumin

13.6.1.1.1.3.  Recombinant Human Serum Albumin

13.6.1.1.2.  Hormones

13.6.1.1.3.  Attachment Factors

13.6.1.1.4.  Amino Acid

13.6.1.1.5.  Growth factors and Cytokines

13.6.1.1.5.1.  Tumor Necrosis Factors

13.6.1.1.5.2.  Insulin-Like Growth Factors

13.6.1.1.5.3.  Interferons

13.6.1.1.5.4.  Interleukins

13.6.1.2.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.6.1.2.1.  Chemically-Defined Media

13.6.1.2.2.  Classical Media

13.6.1.2.3.  Lysogeny Broth

13.6.1.2.4.  Protein-Free Media

13.6.1.2.5.  Serum-Free Media

13.6.1.2.6.  Specialty Media

13.6.1.3.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.3.1.  Biopharmaceuticals and Therapeutics

13.6.1.3.2.  Biotech Research

13.6.1.3.3.  Cancer

13.6.1.3.4.  Drug Screening and Drug Development

13.6.1.3.5.  Regenerative Medicine and Tissue Engineering

13.6.1.3.6.  Stem Cell Technologies

13.6.1.4.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.6.1.4.1.  Biotechnology and Pharmaceutical Companies

13.6.1.4.2.  Research Laboratories

13.6.1.4.3.  Academic Institutes

13.6.1.4.4.  Pathology Labs

13.6.2. Rest of Latin America

13.6.2.1.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.6.2.1.1.  Albumin

13.6.2.1.1.1.  Bovine Serum Albumin

13.6.2.1.1.2.  Human Serum Albumin

13.6.2.1.1.3.  Recombinant Human Serum Albumin

13.6.2.1.2.  Hormones

13.6.2.1.3.  Attachment Factors

13.6.2.1.4.  Amino Acid

13.6.2.1.5.  Growth factors and Cytokines

13.6.2.1.5.1.  Tumor Necrosis Factors

13.6.2.1.5.2.  Insulin-Like Growth Factors

13.6.2.1.5.3.  Interferons

13.6.2.1.5.4.  Interleukins

13.6.2.2.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.6.2.2.1.  Chemically-Defined Media

13.6.2.2.2.  Classical Media

13.6.2.2.3.  Lysogeny Broth

13.6.2.2.4.  Protein-Free Media

13.6.2.2.5.  Serum-Free Media

13.6.2.2.6.  Specialty Media

13.6.2.3.  Rest of Latin America Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.3.1.  Biopharmaceuticals and Therapeutics

13.6.2.3.2.  Biotech Research

13.6.2.3.3.  Cancer

13.6.2.3.4.  Drug Screening and Drug Development

13.6.2.3.5.  Regenerative Medicine and Tissue Engineering

13.6.2.3.6.  Stem Cell Technologies

13.6.2.4.  Rest of Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.6.2.4.1.  Biotechnology and Pharmaceutical Companies

13.6.2.4.2.  Research Laboratories

13.6.2.4.3.  Academic Institutes

13.6.2.4.4.  Pathology Labs

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Reagent Type

13.7.3. By Type

13.7.4. By Application

13.7.5. By End User

14. Competitive Benchmarking

14.1. Player Positioning Analysis

14.2. Global Presence and Growth Strategies

15. Player Profiles

15.1. Affymetrix, Inc.

15.1.1. Company Details

15.1.2. Company Overview

15.1.3. Product Offerings

15.1.4. Key Developments

15.1.5. Financial Analysis

15.1.6. SWOT Analysis

15.1.7. Business Strategies

15.2. Analytical Biological Services Inc.

15.2.1. Company Details

15.2.2. Company Overview

15.2.3. Product Offerings

15.2.4. Key Developments

15.2.5. Financial Analysis

15.2.6. SWOT Analysis

15.2.7. Business Strategies

15.3. BD Biosciences

15.3.1. Company Details

15.3.2. Company Overview

15.3.3. Product Offerings

15.3.4. Key Developments

15.3.5. Financial Analysis

15.3.6. SWOT Analysis

15.3.7. Business Strategies

15.4. Bio-Techne Corporation

15.4.1. Company Details

15.4.2. Company Overview

15.4.3. Product Offerings

15.4.4. Key Developments

15.4.5. Financial Analysis

15.4.6. SWOT Analysis

15.4.7. Business Strategies

15.5. Cell Essentials, Inc.

15.5.1. Company Details

15.5.2. Company Overview

15.5.3. Product Offerings

15.5.4. Key Developments

15.5.5. Financial Analysis

15.5.6. SWOT Analysis

15.5.7. Business Strategies

15.6. ClonTech Laboratories, Inc.

15.6.1. Company Details

15.6.2. Company Overview

15.6.3. Product Offerings

15.6.4. Key Developments

15.6.5. Financial Analysis

15.6.6. SWOT Analysis

15.6.7. Business Strategies

15.7. GE Healthcare

15.7.1. Company Details

15.7.2. Company Overview

15.7.3. Product Offerings

15.7.4. Key Developments

15.7.5. Financial Analysis

15.7.6. SWOT Analysis

15.7.7. Business Strategies

15.8. J R Scientific Inc.

15.8.1. Company Details

15.8.2. Company Overview

15.8.3. Product Offerings

15.8.4. Key Developments

15.8.5. Financial Analysis

15.8.6. SWOT Analysis

15.8.7. Business Strategies

15.9. Johnson & Johnson

15.9.1. Company Details

15.9.2. Company Overview

15.9.3. Product Offerings

15.9.4. Key Developments

15.9.5. Financial Analysis

15.9.6. SWOT Analysis

15.9.7. Business Strategies

15.10. Lonza

15.10.1.  Company Details

15.10.2.  Company Overview

15.10.3.  Product Offerings

15.10.4.  Key Developments

15.10.5.  Financial Analysis

15.10.6.  SWOT Analysis

15.10.7.  Business Strategies

15.11. Merck KGaA

15.11.1.  Company Details

15.11.2.  Company Overview

15.11.3.  Product Offerings

15.11.4.  Key Developments

15.11.5.  Financial Analysis

15.11.6.  SWOT Analysis

15.11.7.  Business Strategies

15.12. MP Biomedicals

15.12.1.  Company Details

15.12.2.  Company Overview

15.12.3.  Product Offerings

15.12.4.  Key Developments

15.12.5.  Financial Analysis

15.12.6.  SWOT Analysis

15.12.7.  Business Strategies

15.13. Novozymes A/S

15.13.1.  Company Details

15.13.2.  Company Overview

15.13.3.  Product Offerings

15.13.4.  Key Developments

15.13.5.  Financial Analysis

15.13.6.  SWOT Analysis

15.13.7.  Business Strategies

15.14. Quality Biological, Inc.

15.14.1.  Company Details

15.14.2.  Company Overview

15.14.3.  Product Offerings

15.14.4.  Key Developments

15.14.5.  Financial Analysis

15.14.6.  SWOT Analysis

15.14.7.  Business Strategies

15.15. SeraCare Life Sciences, Inc.

15.15.1.  Company Details

15.15.2.  Company Overview

15.15.3.  Product Offerings

15.15.4.  Key Developments

15.15.5.  Financial Analysis

15.15.6.  SWOT Analysis

15.15.7.  Business Strategies

15.16. SIAM Bioscience

15.16.1.  Company Details

15.16.2.  Company Overview

15.16.3.  Product Offerings

15.16.4.  Key Developments

15.16.5.  Financial Analysis

15.16.6.  SWOT Analysis

15.16.7.  Business Strategies

15.17. Stemcell Technologies Inc.

15.17.1.  Company Details

15.17.2.  Company Overview

15.17.3.  Product Offerings

15.17.4.  Key Developments

15.17.5.  Financial Analysis

15.17.6.  SWOT Analysis

15.17.7.  Business Strategies

15.18. Thermo Fisher Scientific, Inc.

15.18.1.  Company Details

15.18.2.  Company Overview

15.18.3.  Product Offerings

15.18.4.  Key Developments

15.18.5.  Financial Analysis

15.18.6.  SWOT Analysis

15.18.7.  Business Strategies

 

 

 Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

1.    Introduction

1.1.   Market Scope

1.2.   Market Segmentation

1.3.   Methodology

1.4.   Assumptions

2.    Cell Culture Media Market Snapshot

3.    Executive Summary: Cell Culture Media Market

4.    Qualitative Analysis: Cell Culture Media Market

4.1.   Introduction

4.1.1.   Product Definition

4.1.2.   Industry Development

4.2.   Market Dynamics

4.2.1.   Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.3.   Trends in Market

5.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Market Revenue (US$ Mn) and Forecasts

5.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

5.2.1.   Albumin (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Bovine Serum Albumin, Human Serum Albumin, Recombinant Human Serum Albumin)

5.2.1.1.    Bovine Serum Albumin

5.2.1.2.    Human Serum Albumin

5.2.1.3.    Recombinant Human Serum Albumin

5.2.2.   Hormones

5.2.2.1.    Definition

5.2.2.2.    Market Penetration

5.2.2.3.    Market Revenue Expected to Increase by 2026

5.2.2.4.    Compound Annual Growth Rate (CAGR)

5.2.3.   Attachment Factors

5.2.3.1.    Definition

5.2.3.2.    Market Penetration

5.2.3.3.    Market Revenue Expected to Increase by 2026

5.2.3.4.    Compound Annual Growth Rate (CAGR)

5.2.4.   Amino Acid

5.2.4.1.    Definition

5.2.4.2.    Market Penetration

5.2.4.3.    Market Revenue Expected to Increase by 2026

5.2.4.4.    Compound Annual Growth Rate (CAGR)

5.2.5.   Growth factors and Cytokines (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Tumor Necrosis Factors, Insulin-Like Growth Factors, Interferons, Interleukins)

5.2.5.1.    Tumor Necrosis Factors

5.2.5.2.    Insulin-Like Growth Factors

5.2.5.3.    Interferons

5.2.5.4.    Interleukins

5.3.   Key Segment for Channeling Investments

5.3.1.   By Reagent Type

6.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Market Revenue (US$ Mn) and Forecasts, By Type

6.2.1.   Chemically-Defined Media

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2.   Classical Media

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3.   Lysogeny Broth

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.2.4.   Protein-Free Media

6.2.4.1.    Definition

6.2.4.2.    Market Penetration

6.2.4.3.    Market Revenue Expected to Increase by 2026

6.2.4.4.    Compound Annual Growth Rate (CAGR)

6.2.5.   Serum-Free Media

6.2.5.1.    Definition

6.2.5.2.    Market Penetration

6.2.5.3.    Market Revenue Expected to Increase by 2026

6.2.5.4.    Compound Annual Growth Rate (CAGR)

6.2.6.   Specialty Media

6.2.6.1.    Definition

6.2.6.2.    Market Penetration

6.2.6.3.    Market Revenue Expected to Increase by 2026

6.2.6.4.    Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1.   By Type

7.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   Global Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

7.2.1.   Biopharmaceuticals and Therapeutics

7.2.1.1.    Definition

7.2.1.2.    Market Penetration

7.2.1.3.    Market Revenue Expected to Increase by 2026

7.2.1.4.    Compound Annual Growth Rate (CAGR)

7.2.2.   Biotech Research

7.2.2.1.    Definition

7.2.2.2.    Market Penetration

7.2.2.3.    Market Revenue Expected to Increase by 2026

7.2.2.4.    Compound Annual Growth Rate (CAGR)

7.2.3.   Cancer

7.2.3.1.    Definition

7.2.3.2.    Market Penetration

7.2.3.3.    Market Revenue Expected to Increase by 2026

7.2.3.4.    Compound Annual Growth Rate (CAGR)

7.2.4.   Drug Screening and Drug Development

7.2.4.1.    Definition

7.2.4.2.    Market Penetration

7.2.4.3.    Market Revenue Expected to Increase by 2026

7.2.4.4.    Compound Annual Growth Rate (CAGR)

7.2.5.   Regenerative Medicine and Tissue Engineering

7.2.5.1.    Definition

7.2.5.2.    Market Penetration

7.2.5.3.    Market Revenue Expected to Increase by 2026

7.2.5.4.    Compound Annual Growth Rate (CAGR)

7.2.6.   Stem Cell Technologies

7.2.6.1.    Definition

7.2.6.2.    Market Penetration

7.2.6.3.    Market Revenue Expected to Increase by 2026

7.2.6.4.    Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By Application

8.    Global Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.2.   Global Market Revenue (US$ Mn) and Forecasts, By End User

8.2.1.   Biotechnology and Pharmaceutical Companies

8.2.1.1.    Definition

8.2.1.2.    Market Penetration

8.2.1.3.    Market Revenue Expected to Increase by 2026

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.2.   Research Laboratories

8.2.2.1.    Definition

8.2.2.2.    Market Penetration

8.2.2.3.    Market Revenue Expected to Increase by 2026

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.3.   Academic Institutes

8.2.3.1.    Definition

8.2.3.2.    Market Penetration

8.2.3.3.    Market Revenue Expected to Increase by 2026

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.4.   Pathology Labs

8.2.4.1.    Definition

8.2.4.2.    Market Penetration

8.2.4.3.    Market Revenue Expected to Increase by 2026

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.3.   Key Segment for Channeling Investments

8.3.1.   By End User

9.    North America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   North America Market Revenue (US$ Mn)

9.2.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.2.1.   Albumin

9.2.1.1.    Bovine Serum Albumin

9.2.1.2.    Human Serum Albumin

9.2.1.3.    Recombinant Human Serum Albumin

9.2.2.   Hormones

9.2.3.   Attachment Factors

9.2.4.   Amino Acid

9.2.5.   Growth factors and Cytokines

9.2.5.1.    Tumor Necrosis Factors

9.2.5.2.    Insulin-Like Growth Factors

9.2.5.3.    Interferons

9.2.5.4.    Interleukins

9.3.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.3.1.   Chemically-Defined Media

9.3.2.   Classical Media

9.3.3.   Lysogeny Broth

9.3.4.   Protein-Free Media

9.3.5.   Serum-Free Media

9.3.6.   Specialty Media

9.4.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.   Biopharmaceuticals and Therapeutics

9.4.2.   Biotech Research

9.4.3.   Cancer

9.4.4.   Drug Screening and Drug Development

9.4.5.   Regenerative Medicine and Tissue Engineering

9.4.6.   Stem Cell Technologies

9.5.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.5.1.   Biotechnology and Pharmaceutical Companies

9.5.2.   Research Laboratories

9.5.3.   Academic Institutes

9.5.4.   Pathology Labs

9.6.   North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

9.6.1.   U.S.

9.6.1.1.    U.S. Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.1.1.1.    Albumin

9.6.1.1.1.1.  Bovine Serum Albumin

9.6.1.1.1.2.  Human Serum Albumin

9.6.1.1.1.3.  Recombinant Human Serum Albumin

9.6.1.1.2.    Hormones

9.6.1.1.3.    Attachment Factors

9.6.1.1.4.    Amino Acid

9.6.1.1.5.    Growth factors and Cytokines

9.6.1.1.5.1.  Tumor Necrosis Factors

9.6.1.1.5.2.  Insulin-Like Growth Factors

9.6.1.1.5.3.  Interferons

9.6.1.1.5.4.  Interleukins

9.6.1.2.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.1.2.1.    Chemically-Defined Media

9.6.1.2.2.    Classical Media

9.6.1.2.3.    Lysogeny Broth

9.6.1.2.4.    Protein-Free Media

9.6.1.2.5.    Serum-Free Media

9.6.1.2.6.    Specialty Media

9.6.1.3.    U.S. Market Revenue (US$ Mn) and Forecasts, By Application

9.6.1.3.1.    Biopharmaceuticals and Therapeutics

9.6.1.3.2.    Biotech Research

9.6.1.3.3.    Cancer

9.6.1.3.4.    Drug Screening and Drug Development

9.6.1.3.5.    Regenerative Medicine and Tissue Engineering

9.6.1.3.6.    Stem Cell Technologies

9.6.1.4.    U.S. Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.1.4.1.    Biotechnology and Pharmaceutical Companies

9.6.1.4.2.    Research Laboratories

9.6.1.4.3.    Academic Institutes

9.6.1.4.4.    Pathology Labs

9.6.2.   Rest of North America

9.6.2.1.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

9.6.2.1.1.    Albumin

9.6.2.1.1.1.  Bovine Serum Albumin

9.6.2.1.1.2.  Human Serum Albumin

9.6.2.1.1.3.  Recombinant Human Serum Albumin

9.6.2.1.2.    Hormones

9.6.2.1.3.    Attachment Factors

9.6.2.1.4.    Amino Acid

9.6.2.1.5.    Growth factors and Cytokines

9.6.2.1.5.1.  Tumor Necrosis Factors

9.6.2.1.5.2.  Insulin-Like Growth Factors

9.6.2.1.5.3.  Interferons

9.6.2.1.5.4.  Interleukins

9.6.2.2.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

9.6.2.2.1.    Chemically-Defined Media

9.6.2.2.2.    Classical Media

9.6.2.2.3.    Lysogeny Broth

9.6.2.2.4.    Protein-Free Media

9.6.2.2.5.    Serum-Free Media

9.6.2.2.6.    Specialty Media

9.6.2.3.    Rest of North America Market Revenue (US$ Mn) and Forecasts, By Application

9.6.2.3.1.    Biopharmaceuticals and Therapeutics

9.6.2.3.2.    Biotech Research

9.6.2.3.3.    Cancer

9.6.2.3.4.    Drug Screening and Drug Development

9.6.2.3.5.    Regenerative Medicine and Tissue Engineering

9.6.2.3.6.    Stem Cell Technologies

9.6.2.4.    Rest of North America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

9.6.2.4.1.    Biotechnology and Pharmaceutical Companies

9.6.2.4.2.    Research Laboratories

9.6.2.4.3.    Academic Institutes

9.6.2.4.4.    Pathology Labs

9.7.   Key Segment for Channeling Investments

9.7.1.   By Country

9.7.2.   By Reagent Type

9.7.3.   By Type

9.7.4.   By Application

9.7.5.   By End User

10. Europe Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Europe Market Revenue (US$ Mn)

10.2. Europe Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.2.1. Albumin

10.2.1.1.  Bovine Serum Albumin

10.2.1.2.  Human Serum Albumin

10.2.1.3.  Recombinant Human Serum Albumin

10.2.2. Hormones

10.2.3. Attachment Factors

10.2.4. Amino Acid

10.2.5. Growth factors and Cytokines

10.2.5.1.  Tumor Necrosis Factors

10.2.5.2.  Insulin-Like Growth Factors

10.2.5.3.  Interferons

10.2.5.4.  Interleukins

10.3. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.3.1. Chemically-Defined Media

10.3.2. Classical Media

10.3.3. Lysogeny Broth

10.3.4. Protein-Free Media

10.3.5. Serum-Free Media

10.3.6. Specialty Media

10.4. Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1. Biopharmaceuticals and Therapeutics

10.4.2. Biotech Research

10.4.3. Cancer

10.4.4. Drug Screening and Drug Development

10.4.5. Regenerative Medicine and Tissue Engineering

10.4.6. Stem Cell Technologies

10.5. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.5.1. Biotechnology and Pharmaceutical Companies

10.5.2. Research Laboratories

10.5.3. Academic Institutes

10.5.4. Pathology Labs

10.6. Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

10.6.1. France

10.6.1.1.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.1.1.1.  Albumin

10.6.1.1.1.1.  Bovine Serum Albumin

10.6.1.1.1.2.  Human Serum Albumin

10.6.1.1.1.3.  Recombinant Human Serum Albumin

10.6.1.1.2.  Hormones

10.6.1.1.3.  Attachment Factors

10.6.1.1.4.  Amino Acid

10.6.1.1.5.  Growth factors and Cytokines

10.6.1.1.5.1.  Tumor Necrosis Factors

10.6.1.1.5.2.  Insulin-Like Growth Factors

10.6.1.1.5.3.  Interferons

10.6.1.1.5.4.  Interleukins

10.6.1.2.  France Market Revenue (US$ Mn) and Forecasts, By Type

10.6.1.2.1.  Chemically-Defined Media

10.6.1.2.2.  Classical Media

10.6.1.2.3.  Lysogeny Broth

10.6.1.2.4.  Protein-Free Media

10.6.1.2.5.  Serum-Free Media

10.6.1.2.6.  Specialty Media

10.6.1.3.  France Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.1.3.1.  Biopharmaceuticals and Therapeutics

10.6.1.3.2.  Biotech Research

10.6.1.3.3.  Cancer

10.6.1.3.4.  Drug Screening and Drug Development

10.6.1.3.5.  Regenerative Medicine and Tissue Engineering

10.6.1.3.6.  Stem Cell Technologies

10.6.1.4.  France Market Revenue (US$ Mn) and Forecasts, By End User

10.6.1.4.1.  Biotechnology and Pharmaceutical Companies

10.6.1.4.2.  Research Laboratories

10.6.1.4.3.  Academic Institutes

10.6.1.4.4.  Pathology Labs

10.6.2. The UK

10.6.2.1.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.2.1.1.  Albumin

10.6.2.1.1.1.  Bovine Serum Albumin

10.6.2.1.1.2.  Human Serum Albumin

10.6.2.1.1.3.  Recombinant Human Serum Albumin

10.6.2.1.2.  Hormones

10.6.2.1.3.  Attachment Factors

10.6.2.1.4.  Amino Acid

10.6.2.1.5.  Growth factors and Cytokines

10.6.2.1.5.1.  Tumor Necrosis Factors

10.6.2.1.5.2.  Insulin-Like Growth Factors

10.6.2.1.5.3.  Interferons

10.6.2.1.5.4.  Interleukins

10.6.2.2.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.2.2.1.  Chemically-Defined Media

10.6.2.2.2.  Classical Media

10.6.2.2.3.  Lysogeny Broth

10.6.2.2.4.  Protein-Free Media

10.6.2.2.5.  Serum-Free Media

10.6.2.2.6.  Specialty Media

10.6.2.3.  The UK Market Revenue (US$ Mn) and Forecasts, By Application

10.6.2.3.1.  Biopharmaceuticals and Therapeutics

10.6.2.3.2.  Biotech Research

10.6.2.3.3.  Cancer

10.6.2.3.4.  Drug Screening and Drug Development

10.6.2.3.5.  Regenerative Medicine and Tissue Engineering

10.6.2.3.6.  Stem Cell Technologies

10.6.2.4.  The UK Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.2.4.1.  Biotechnology and Pharmaceutical Companies

10.6.2.4.2.  Research Laboratories

10.6.2.4.3.  Academic Institutes

10.6.2.4.4.  Pathology Labs

10.6.3. Spain

10.6.3.1.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.3.1.1.  Albumin

10.6.3.1.1.1.  Bovine Serum Albumin

10.6.3.1.1.2.  Human Serum Albumin

10.6.3.1.1.3.  Recombinant Human Serum Albumin

10.6.3.1.2.  Hormones

10.6.3.1.3.  Attachment Factors

10.6.3.1.4.  Amino Acid

10.6.3.1.5.  Growth factors and Cytokines

10.6.3.1.5.1.  Tumor Necrosis Factors

10.6.3.1.5.2.  Insulin-Like Growth Factors

10.6.3.1.5.3.  Interferons

10.6.3.1.5.4.  Interleukins

10.6.3.2.  Spain Market Revenue (US$ Mn) and Forecasts, By Type

10.6.3.2.1.  Chemically-Defined Media

10.6.3.2.2.  Classical Media

10.6.3.2.3.  Lysogeny Broth

10.6.3.2.4.  Protein-Free Media

10.6.3.2.5.  Serum-Free Media

10.6.3.2.6.  Specialty Media

10.6.3.3.  Spain Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.3.3.1.  Biopharmaceuticals and Therapeutics

10.6.3.3.2.  Biotech Research

10.6.3.3.3.  Cancer

10.6.3.3.4.  Drug Screening and Drug Development

10.6.3.3.5.  Regenerative Medicine and Tissue Engineering

10.6.3.3.6.  Stem Cell Technologies

10.6.3.4.  Spain Market Revenue (US$ Mn) and Forecasts, By End User

10.6.3.4.1.  Biotechnology and Pharmaceutical Companies

10.6.3.4.2.  Research Laboratories

10.6.3.4.3.  Academic Institutes

10.6.3.4.4.  Pathology Labs

10.6.4. Germany

10.6.4.1.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.4.1.1.  Albumin

10.6.4.1.1.1.  Bovine Serum Albumin

10.6.4.1.1.2.  Human Serum Albumin

10.6.4.1.1.3.  Recombinant Human Serum Albumin

10.6.4.1.2.  Hormones

10.6.4.1.3.  Attachment Factors

10.6.4.1.4.  Amino Acid

10.6.4.1.5.  Growth factors and Cytokines

10.6.4.1.5.1.  Tumor Necrosis Factors

10.6.4.1.5.2.  Insulin-Like Growth Factors

10.6.4.1.5.3.  Interferons

10.6.4.1.5.4.  Interleukins

10.6.4.2.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.4.2.1.  Chemically-Defined Media

10.6.4.2.2.  Classical Media

10.6.4.2.3.  Lysogeny Broth

10.6.4.2.4.  Protein-Free Media

10.6.4.2.5.  Serum-Free Media

10.6.4.2.6.  Specialty Media

10.6.4.3.  Germany Market Revenue (US$ Mn) and Forecasts, By Application

10.6.4.3.1.  Biopharmaceuticals and Therapeutics

10.6.4.3.2.  Biotech Research

10.6.4.3.3.  Cancer

10.6.4.3.4.  Drug Screening and Drug Development

10.6.4.3.5.  Regenerative Medicine and Tissue Engineering

10.6.4.3.6.  Stem Cell Technologies

10.6.4.4.  Germany Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.4.4.1.  Biotechnology and Pharmaceutical Companies

10.6.4.4.2.  Research Laboratories

10.6.4.4.3.  Academic Institutes

10.6.4.4.4.  Pathology Labs

10.6.5. Italy

10.6.5.1.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.5.1.1.  Albumin

10.6.5.1.1.1.  Bovine Serum Albumin

10.6.5.1.1.2.  Human Serum Albumin

10.6.5.1.1.3.  Recombinant Human Serum Albumin

10.6.5.1.2.  Hormones

10.6.5.1.3.  Attachment Factors

10.6.5.1.4.  Amino Acid

10.6.5.1.5.  Growth factors and Cytokines

10.6.5.1.5.1.  Tumor Necrosis Factors

10.6.5.1.5.2.  Insulin-Like Growth Factors

10.6.5.1.5.3.  Interferons

10.6.5.1.5.4.  Interleukins

10.6.5.2.  Italy Market Revenue (US$ Mn) and Forecasts, By Type

10.6.5.2.1.  Chemically-Defined Media

10.6.5.2.2.  Classical Media

10.6.5.2.3.  Lysogeny Broth

10.6.5.2.4.  Protein-Free Media

10.6.5.2.5.  Serum-Free Media

10.6.5.2.6.  Specialty Media

10.6.5.3.  Italy Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

10.6.5.3.1.  Biopharmaceuticals and Therapeutics

10.6.5.3.2.  Biotech Research

10.6.5.3.3.  Cancer

10.6.5.3.4.  Drug Screening and Drug Development

10.6.5.3.5.  Regenerative Medicine and Tissue Engineering

10.6.5.3.6.  Stem Cell Technologies

10.6.5.4.  Italy Market Revenue (US$ Mn) and Forecasts, By End User

10.6.5.4.1.  Biotechnology and Pharmaceutical Companies

10.6.5.4.2.  Research Laboratories

10.6.5.4.3.  Academic Institutes

10.6.5.4.4.  Pathology Labs

10.6.6. Rest of Europe

10.6.6.1.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

10.6.6.1.1.  Albumin

10.6.6.1.1.1.  Bovine Serum Albumin

10.6.6.1.1.2.  Human Serum Albumin

10.6.6.1.1.3.  Recombinant Human Serum Albumin

10.6.6.1.2.  Hormones

10.6.6.1.3.  Attachment Factors

10.6.6.1.4.  Amino Acid

10.6.6.1.5.  Growth factors and Cytokines

10.6.6.1.5.1.  Tumor Necrosis Factors

10.6.6.1.5.2.  Insulin-Like Growth Factors

10.6.6.1.5.3.  Interferons

10.6.6.1.5.4.  Interleukins

10.6.6.2.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

10.6.6.2.1.  Chemically-Defined Media

10.6.6.2.2.  Classical Media

10.6.6.2.3.  Lysogeny Broth

10.6.6.2.4.  Protein-Free Media

10.6.6.2.5.  Serum-Free Media

10.6.6.2.6.  Specialty Media

10.6.6.3.  Rest of Europe Market Revenue (US$ Mn) and Forecasts, By Application

10.6.6.3.1.  Biopharmaceuticals and Therapeutics

10.6.6.3.2.  Biotech Research

10.6.6.3.3.  Cancer

10.6.6.3.4.  Drug Screening and Drug Development

10.6.6.3.5.  Regenerative Medicine and Tissue Engineering

10.6.6.3.6.  Stem Cell Technologies

10.6.6.4.  Rest of Europe Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

10.6.6.4.1.  Biotechnology and Pharmaceutical Companies

10.6.6.4.2.  Research Laboratories

10.6.6.4.3.  Academic Institutes

10.6.6.4.4.  Pathology Labs

10.7. Key Segment for Channeling Investments

10.7.1. By Country

10.7.2. By Reagent Type

10.7.3. By Type

10.7.4. By Application

10.7.5. By End User

11. Asia Pacific Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Asia Pacific Market Revenue (US$ Mn)

11.2. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.2.1. Albumin

11.2.1.1.  Bovine Serum Albumin

11.2.1.2.  Human Serum Albumin

11.2.1.3.  Recombinant Human Serum Albumin

11.2.2. Hormones

11.2.3. Attachment Factors

11.2.4. Amino Acid

11.2.5. Growth factors and Cytokines

11.2.5.1.  Tumor Necrosis Factors

11.2.5.2.  Insulin-Like Growth Factors

11.2.5.3.  Interferons

11.2.5.4.  Interleukins

11.3. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.3.1. Chemically-Defined Media

11.3.2. Classical Media

11.3.3. Lysogeny Broth

11.3.4. Protein-Free Media

11.3.5. Serum-Free Media

11.3.6. Specialty Media

11.4. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1. Biopharmaceuticals and Therapeutics

11.4.2. Biotech Research

11.4.3. Cancer

11.4.4. Drug Screening and Drug Development

11.4.5. Regenerative Medicine and Tissue Engineering

11.4.6. Stem Cell Technologies

11.5. Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.5.1. Biotechnology and Pharmaceutical Companies

11.5.2. Research Laboratories

11.5.3. Academic Institutes

11.5.4. Pathology Labs

11.6. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By Country

11.6.1. China

11.6.1.1.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.1.1.1.  Albumin

11.6.1.1.1.1.  Bovine Serum Albumin

11.6.1.1.1.2.  Human Serum Albumin

11.6.1.1.1.3.  Recombinant Human Serum Albumin

11.6.1.1.2.  Hormones

11.6.1.1.3.  Attachment Factors

11.6.1.1.4.  Amino Acid

11.6.1.1.5.  Growth factors and Cytokines

11.6.1.1.5.1.  Tumor Necrosis Factors

11.6.1.1.5.2.  Insulin-Like Growth Factors

11.6.1.1.5.3.  Interferons

11.6.1.1.5.4.  Interleukins

11.6.1.2.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.1.2.1.  Chemically-Defined Media

11.6.1.2.2.  Classical Media

11.6.1.2.3.  Lysogeny Broth

11.6.1.2.4.  Protein-Free Media

11.6.1.2.5.  Serum-Free Media

11.6.1.2.6.  Specialty Media

11.6.1.3.  China Market Revenue (US$ Mn) and Forecasts, By Application

11.6.1.3.1.  Biopharmaceuticals and Therapeutics

11.6.1.3.2.  Biotech Research

11.6.1.3.3.  Cancer

11.6.1.3.4.  Drug Screening and Drug Development

11.6.1.3.5.  Regenerative Medicine and Tissue Engineering

11.6.1.3.6.  Stem Cell Technologies

11.6.1.4.  China Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.1.4.1.  Biotechnology and Pharmaceutical Companies

11.6.1.4.2.  Research Laboratories

11.6.1.4.3.  Academic Institutes

11.6.1.4.4.  Pathology Labs

11.6.2. Japan

11.6.2.1.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.2.1.1.  Albumin

11.6.2.1.1.1.  Bovine Serum Albumin

11.6.2.1.1.2.  Human Serum Albumin

11.6.2.1.1.3.  Recombinant Human Serum Albumin

11.6.2.1.2.  Hormones

11.6.2.1.3.  Attachment Factors

11.6.2.1.4.  Amino Acid

11.6.2.1.5.  Growth factors and Cytokines

11.6.2.1.5.1.  Tumor Necrosis Factors

11.6.2.1.5.2.  Insulin-Like Growth Factors

11.6.2.1.5.3.  Interferons

11.6.2.1.5.4.  Interleukins

11.6.2.2.  Japan Market Revenue (US$ Mn) and Forecasts, By Type

11.6.2.2.1.  Chemically-Defined Media

11.6.2.2.2.  Classical Media

11.6.2.2.3.  Lysogeny Broth

11.6.2.2.4.  Protein-Free Media

11.6.2.2.5.  Serum-Free Media

11.6.2.2.6.  Specialty Media

11.6.2.3.  Japan Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.2.3.1.  Biopharmaceuticals and Therapeutics

11.6.2.3.2.  Biotech Research

11.6.2.3.3.  Cancer

11.6.2.3.4.  Drug Screening and Drug Development

11.6.2.3.5.  Regenerative Medicine and Tissue Engineering

11.6.2.3.6.  Stem Cell Technologies

11.6.2.4.  Japan Market Revenue (US$ Mn) and Forecasts, By End User

11.6.2.4.1.  Biotechnology and Pharmaceutical Companies

11.6.2.4.2.  Research Laboratories

11.6.2.4.3.  Academic Institutes

11.6.2.4.4.  Pathology Labs

11.6.3. India

11.6.3.1.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.3.1.1.  Albumin

11.6.3.1.1.1.  Bovine Serum Albumin

11.6.3.1.1.2.  Human Serum Albumin

11.6.3.1.1.3.  Recombinant Human Serum Albumin

11.6.3.1.2.  Hormones

11.6.3.1.3.  Attachment Factors

11.6.3.1.4.  Amino Acid

11.6.3.1.5.  Growth factors and Cytokines

11.6.3.1.5.1.  Tumor Necrosis Factors

11.6.3.1.5.2.  Insulin-Like Growth Factors

11.6.3.1.5.3.  Interferons

11.6.3.1.5.4.  Interleukins

11.6.3.2.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.3.2.1.  Chemically-Defined Media

11.6.3.2.2.  Classical Media

11.6.3.2.3.  Lysogeny Broth

11.6.3.2.4.  Protein-Free Media

11.6.3.2.5.  Serum-Free Media

11.6.3.2.6.  Specialty Media

11.6.3.3.  India Market Revenue (US$ Mn) and Forecasts, By Application

11.6.3.3.1.  Biopharmaceuticals and Therapeutics

11.6.3.3.2.  Biotech Research

11.6.3.3.3.  Cancer

11.6.3.3.4.  Drug Screening and Drug Development

11.6.3.3.5.  Regenerative Medicine and Tissue Engineering

11.6.3.3.6.  Stem Cell Technologies

11.6.3.4.  India Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.3.4.1.  Biotechnology and Pharmaceutical Companies

11.6.3.4.2.  Research Laboratories

11.6.3.4.3.  Academic Institutes

11.6.3.4.4.  Pathology Labs

11.6.4. Southeast Asia

11.6.4.1.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.4.1.1.  Albumin

11.6.4.1.1.1.  Bovine Serum Albumin

11.6.4.1.1.2.  Human Serum Albumin

11.6.4.1.1.3.  Recombinant Human Serum Albumin

11.6.4.1.2.  Hormones

11.6.4.1.3.  Attachment Factors

11.6.4.1.4.  Amino Acid

11.6.4.1.5.  Growth factors and Cytokines

11.6.4.1.5.1.  Tumor Necrosis Factors

11.6.4.1.5.2.  Insulin-Like Growth Factors

11.6.4.1.5.3.  Interferons

11.6.4.1.5.4.  Interleukins

11.6.4.2.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.4.2.1.  Chemically-Defined Media

11.6.4.2.2.  Classical Media

11.6.4.2.3.  Lysogeny Broth

11.6.4.2.4.  Protein-Free Media

11.6.4.2.5.  Serum-Free Media

11.6.4.2.6.  Specialty Media

11.6.4.3.  Southeast Asia Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.4.3.1.  Biopharmaceuticals and Therapeutics

11.6.4.3.2.  Biotech Research

11.6.4.3.3.  Cancer

11.6.4.3.4.  Drug Screening and Drug Development

11.6.4.3.5.  Regenerative Medicine and Tissue Engineering

11.6.4.3.6.  Stem Cell Technologies

11.6.4.4.  Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End User

11.6.4.4.1.  Biotechnology and Pharmaceutical Companies

11.6.4.4.2.  Research Laboratories

11.6.4.4.3.  Academic Institutes

11.6.4.4.4.  Pathology Labs

11.6.5. Rest of Asia Pacific

11.6.5.1.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

11.6.5.1.1.  Albumin

11.6.5.1.1.1.  Bovine Serum Albumin

11.6.5.1.1.2.  Human Serum Albumin

11.6.5.1.1.3.  Recombinant Human Serum Albumin

11.6.5.1.2.  Hormones

11.6.5.1.3.  Attachment Factors

11.6.5.1.4.  Amino Acid

11.6.5.1.5.  Growth factors and Cytokines

11.6.5.1.5.1.  Tumor Necrosis Factors

11.6.5.1.5.2.  Insulin-Like Growth Factors

11.6.5.1.5.3.  Interferons

11.6.5.1.5.4.  Interleukins

11.6.5.2.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

11.6.5.2.1.  Chemically-Defined Media

11.6.5.2.2.  Classical Media

11.6.5.2.3.  Lysogeny Broth

11.6.5.2.4.  Protein-Free Media

11.6.5.2.5.  Serum-Free Media

11.6.5.2.6.  Specialty Media

11.6.5.3.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

11.6.5.3.1.  Biopharmaceuticals and Therapeutics

11.6.5.3.2.  Biotech Research

11.6.5.3.3.  Cancer

11.6.5.3.4.  Drug Screening and Drug Development

11.6.5.3.5.  Regenerative Medicine and Tissue Engineering

11.6.5.3.6.  Stem Cell Technologies

11.6.5.4.  Rest of Asia Pacific Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

11.6.5.4.1.  Biotechnology and Pharmaceutical Companies

11.6.5.4.2.  Research Laboratories

11.6.5.4.3.  Academic Institutes

11.6.5.4.4.  Pathology Labs

11.7. Key Segment for Channeling Investments

11.7.1. By Country

11.7.2. By Reagent Type

11.7.3. By Type

11.7.4. By Application

11.7.5. By End User

12. Middle East and Africa Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Middle East and Africa Market Revenue (US$ Mn)

12.2. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.2.1. Albumin

12.2.1.1.  Bovine Serum Albumin

12.2.1.2.  Human Serum Albumin

12.2.1.3.  Recombinant Human Serum Albumin

12.2.2. Hormones

12.2.3. Attachment Factors

12.2.4. Amino Acid

12.2.5. Growth factors and Cytokines

12.2.5.1.  Tumor Necrosis Factors

12.2.5.2.  Insulin-Like Growth Factors

12.2.5.3.  Interferons

12.2.5.4.  Interleukins

12.3. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.3.1. Chemically-Defined Media

12.3.2. Classical Media

12.3.3. Lysogeny Broth

12.3.4. Protein-Free Media

12.3.5. Serum-Free Media

12.3.6. Specialty Media

12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Biopharmaceuticals and Therapeutics

12.4.2. Biotech Research

12.4.3. Cancer

12.4.4. Drug Screening and Drug Development

12.4.5. Regenerative Medicine and Tissue Engineering

12.4.6. Stem Cell Technologies

12.5. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1. Biotechnology and Pharmaceutical Companies

12.5.2. Research Laboratories

12.5.3. Academic Institutes

12.5.4. Pathology Labs

12.6. Middle East and Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. GCC Countries

12.6.1.1.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.1.1.1.  Albumin

12.6.1.1.1.1.  Bovine Serum Albumin

12.6.1.1.1.2.  Human Serum Albumin

12.6.1.1.1.3.  Recombinant Human Serum Albumin

12.6.1.1.2.  Hormones

12.6.1.1.3.  Attachment Factors

12.6.1.1.4.  Amino Acid

12.6.1.1.5.  Growth factors and Cytokines

12.6.1.1.5.1.  Tumor Necrosis Factors

12.6.1.1.5.2.  Insulin-Like Growth Factors

12.6.1.1.5.3.  Interferons

12.6.1.1.5.4.  Interleukins

12.6.1.2.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.1.2.1.  Chemically-Defined Media

12.6.1.2.2.  Classical Media

12.6.1.2.3.  Lysogeny Broth

12.6.1.2.4.  Protein-Free Media

12.6.1.2.5.  Serum-Free Media

12.6.1.2.6.  Specialty Media

12.6.1.3.  GCC Countries Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.3.1.  Biopharmaceuticals and Therapeutics

12.6.1.3.2.  Biotech Research

12.6.1.3.3.  Cancer

12.6.1.3.4.  Drug Screening and Drug Development

12.6.1.3.5.  Regenerative Medicine and Tissue Engineering

12.6.1.3.6.  Stem Cell Technologies

12.6.1.4.  GCC Countries Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.1.4.1.  Biotechnology and Pharmaceutical Companies

12.6.1.4.2.  Research Laboratories

12.6.1.4.3.  Academic Institutes

12.6.1.4.4.  Pathology Labs

12.6.2. Southern Africa

12.6.2.1.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.2.1.1.  Albumin

12.6.2.1.1.1.  Bovine Serum Albumin

12.6.2.1.1.2.  Human Serum Albumin

12.6.2.1.1.3.  Recombinant Human Serum Albumin

12.6.2.1.2.  Hormones

12.6.2.1.3.  Attachment Factors

12.6.2.1.4.  Amino Acid

12.6.2.1.5.  Growth factors and Cytokines

12.6.2.1.5.1.  Tumor Necrosis Factors

12.6.2.1.5.2.  Insulin-Like Growth Factors

12.6.2.1.5.3.  Interferons

12.6.2.1.5.4.  Interleukins

12.6.2.2.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By Type

12.6.2.2.1.  Chemically-Defined Media

12.6.2.2.2.  Classical Media

12.6.2.2.3.  Lysogeny Broth

12.6.2.2.4.  Protein-Free Media

12.6.2.2.5.  Serum-Free Media

12.6.2.2.6.  Specialty Media

12.6.2.3.  Southern Africa Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.3.1.  Biopharmaceuticals and Therapeutics

12.6.2.3.2.  Biotech Research

12.6.2.3.3.  Cancer

12.6.2.3.4.  Drug Screening and Drug Development

12.6.2.3.5.  Regenerative Medicine and Tissue Engineering

12.6.2.3.6.  Stem Cell Technologies

12.6.2.4.  Southern Africa Market Revenue (US$ Mn) and Forecasts, By End User

12.6.2.4.1.  Biotechnology and Pharmaceutical Companies

12.6.2.4.2.  Research Laboratories

12.6.2.4.3.  Academic Institutes

12.6.2.4.4.  Pathology Labs

12.6.3. Rest of MEA

12.6.3.1.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

12.6.3.1.1.  Albumin

12.6.3.1.1.1.  Bovine Serum Albumin

12.6.3.1.1.2.  Human Serum Albumin

12.6.3.1.1.3.  Recombinant Human Serum Albumin

12.6.3.1.2.  Hormones

12.6.3.1.3.  Attachment Factors

12.6.3.1.4.  Amino Acid

12.6.3.1.5.  Growth factors and Cytokines

12.6.3.1.5.1.  Tumor Necrosis Factors

12.6.3.1.5.2.  Insulin-Like Growth Factors

12.6.3.1.5.3.  Interferons

12.6.3.1.5.4.  Interleukins

12.6.3.2.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

12.6.3.2.1.  Chemically-Defined Media

12.6.3.2.2.  Classical Media

12.6.3.2.3.  Lysogeny Broth

12.6.3.2.4.  Protein-Free Media

12.6.3.2.5.  Serum-Free Media

12.6.3.2.6.  Specialty Media

12.6.3.3.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.3.1.  Biopharmaceuticals and Therapeutics

12.6.3.3.2.  Biotech Research

12.6.3.3.3.  Cancer

12.6.3.3.4.  Drug Screening and Drug Development

12.6.3.3.5.  Regenerative Medicine and Tissue Engineering

12.6.3.3.6.  Stem Cell Technologies

12.6.3.4.  Rest of MEA Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

12.6.3.4.1.  Biotechnology and Pharmaceutical Companies

12.6.3.4.2.  Research Laboratories

12.6.3.4.3.  Academic Institutes

12.6.3.4.4.  Pathology Labs

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Reagent Type

12.7.3. By Type

12.7.4. By Application

12.7.5. By End User

13. Latin America Cell Culture Media Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Latin America Market Revenue (US$ Mn)

13.2. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.2.1. Albumin

13.2.1.1.  Bovine Serum Albumin

13.2.1.2.  Human Serum Albumin

13.2.1.3.  Recombinant Human Serum Albumin

13.2.2. Hormones

13.2.3. Attachment Factors

13.2.4. Amino Acid

13.2.5. Growth factors and Cytokines

13.2.5.1.  Tumor Necrosis Factors

13.2.5.2.  Insulin-Like Growth Factors

13.2.5.3.  Interferons

13.2.5.4.  Interleukins

13.3. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.3.1. Chemically-Defined Media

13.3.2. Classical Media

13.3.3. Lysogeny Broth

13.3.4. Protein-Free Media

13.3.5. Serum-Free Media

13.3.6. Specialty Media

13.4. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Biopharmaceuticals and Therapeutics

13.4.2. Biotech Research

13.4.3. Cancer

13.4.4. Drug Screening and Drug Development

13.4.5. Regenerative Medicine and Tissue Engineering

13.4.6. Stem Cell Technologies

13.5. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1. Biotechnology and Pharmaceutical Companies

13.5.2. Research Laboratories

13.5.3. Academic Institutes

13.5.4. Pathology Labs

13.6. Latin America Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. Brazil

13.6.1.1.  Brazil Market Revenue (US$ Mn) and Forecasts, By Reagent Type

13.6.1.1.1.  Albumin

13.6.1.1.1.1.  Bovine Serum Albumin

13.6.1.1.1.2.  Human Serum Albumin

13.6.1.1.1.3.  Recombinant Human Serum Albumin

13.6.1.1.2.  Hormones

13.6.1.1.3.  Attachment Factors

13.6.1.1.4.  Amino Acid

13.6.1.1.5.  Growth factors and Cytokines

13.6.1.1.5.1.  Tumor Necrosis Factors

13.6.1.1.5.2.  Insulin-Like Growth Factors

13.6.1.1.5.3.  Interferons

13.6.1.1.5.4.  Interleukins

13.6.1.2.  Brazil Cell Culture Media Market Revenue (US$ Mn) and Forecasts, By Type

13.6.1.2.1.  Chemically-Defined Media

13.6.1.2.2.  Classical Media

13.6.1.2.3.  Lysogeny Broth

13.6.1.2.4.  Protein-Free Media

13.6.1.2.5.  Serum-Free Media